Dosage form cartridge assembly and dosage form dispenser having the same

Abstract

To improve the convenience of a user by making it convenient to take a dosage form.SOLUTION: The present invention relates to a dosage form cartridge assembly and a dosage form dispenser comprising the same. A dosage form cartridge assembly according to an embodiment of the present invention includes a housing in which a dosage form is located in an inner space, a discharge cap coupled to and fixed to the housing and having a rotor insertion hole opened at a central portion thereof and a discharge port through which the dosage form is discharged to a portion of an edge thereof, and a rotor unit inserted into the rotor insertion hole and rotatably coupled to the rotor insertion hole, the rotor unit including a dosage form guide hole on which the dosage form discharged through the discharge port is seated. The dosage form induction port extends from an inner side of the rotor part in an outward direction, and has a width and a length such that a plurality of dosage forms including a first dosage form and a second dosage form are seated therein and are arranged in a line.SELECTED DRAWING: Figure 4

Description

[Technical Field]

[0001] The present invention relates to a dosage form cartridge assembly and a dosage form dispenser including the same. [Background technology]

[0002] Supplements containing trace elements (zinc, iron, magnesium, etc.) and vitamins are generally recognized as health supplements for the human body.

[0003] However, such supplements may be used as therapeutic agents if necessary, but when used as therapeutic agents, the dosage may be severely limited depending on the patient's condition. For example, patients with osteomalacia should be prescribed vitamin D, and the dosage is determined by the calcium level in their blood. If patients take too much vitamin D, side effects such as calcium stones and hypertensive disease may occur.

[0004] In addition, isoniazid, which is used to treat tuberculosis, can rapidly deplete the niacin (nicotinic acid) in the patient's blood during tuberculosis treatment.

[0005] Therefore, if niacin deficiency occurs, the doctor will determine the appropriate dose of isoniazid for the patient based on the patient's blood niacin level.

[0006] In this way, supplements taken for health reasons may also act as toxic substances that harm health depending on the user's physical condition, such as the presence or absence of underlying diseases, so it is important to take only the types and amounts necessary for the body.

[0007] On the other hand, some patients, such as those with high blood pressure, diabetes, and hypothyroidism, may need to take medication for the rest of their lives. In such cases, the dosage of medication is often adjusted depending on the patient's physical condition.

[0008] However, the medications administered to patients are often tablets with fixed doses, such as 50mg or 100mg, and doctors prescribe graded doses instead of prescribing the exact dose that best suits the patient's condition.

[0009] For example, if a hypertensive patient prescribed a 50 mg dose of a drug experiences a worsening of their condition, rather than increasing the dose to match the severity of the condition, the doctor will prescribe the patient the next available dose, 100 mg.

[0010] As such, it is preferable that dosage forms such as dietary supplements and supplements or tablets taken for therapeutic purposes be taken at the appropriate dose at the specified time according to the user's physical condition.

[0011] However, it is difficult to take the correct dosage form that is right for you. In particular, when taking a dosage form as a health supplement, unlike in the case of an illness, it is very difficult to take the correct dosage form continuously because it does not directly affect the current health of the body. Summary of the Invention [Problem to be solved by the invention]

[0012] The problem that the present invention aims to solve is to make the dosage form more convenient to take, thereby increasing user convenience.

[0013] Another problem that the present invention seeks to solve is that of ensuring rapid ejection without damaging the dosage form. [Means for solving the problem]

[0014] A dosage form cartridge assembly according to one embodiment of the present invention includes a housing in which dosage forms are located within an internal space; a discharge cap that is coupled to and fixed with the housing and has a rotor insertion port that opens in the center and a discharge port at a portion of the edge through which the dosage forms are discharged; and a rotor unit that is inserted into the rotor insertion port and coupled to be rotatable around the rotor insertion port, and has a dosage form induction port in which the dosage forms to be discharged through the discharge port are seated. The dosage form induction port extends from the inside to the outside of the rotor unit and has a width and length that allow multiple dosage forms, including a first dosage form and a second dosage form, to be seated therein and arranged in a line, and as the rotor unit rotates, the multiple dosage forms arranged in the dosage form induction port are sequentially discharged through the discharge port.

[0015] The housing includes a housing body that forms the outer shape of the housing and extends vertically, an insertion limiting portion that is located inside the housing body and spaced apart from the housing body and extends vertically, a connecting portion that extends outward from a lower end of the insertion limiting portion and connects to the housing body, and a dosage form guide protrusion that protrudes downward from the connecting portion and has a portion that overlaps with the discharge port, and when viewed from above the housing body, the outer portion of the rotor portion is hidden by the insertion limiting portion.

[0016] The dosage form guide protrusion includes a portion whose protruding length increases toward the discharge port.

[0017] The lower end of the dosage form guide protrusion includes a first portion having a constant protruding length and a second portion having a protruding length that increases as it approaches the discharge port, and the first portion is located closer to the discharge port than the second portion but overlaps the discharge port vertically.

[0018] The discharge cap surrounds the rotor insertion port and further includes a flat first guide surface, and a second guide surface that is connected to the first guide surface, surrounds the first guide surface, and slopes outward.

[0019] The discharge port is located at a part of the edge of the discharge cap, but is located on an extension line of the second guide surface.

[0020] The distance between the lower end of the portion of the dosage form guide protrusion that overlaps the discharge port and the first guide surface is smaller than the width or height of the dosage form.

[0021] The insertion limiting portion is adjacent to and overlaps vertically with the boundary surface between the first guide surface and the second guide surface.

[0022] The second guide surface includes a first inclined portion inclined toward the outside of the second guide surface and a second inclined portion inclined toward the discharge port, one end of the second inclined surface being positioned in contact with the discharge port, and the other end of the second inclined portion being positioned in contact with the first inclined portion.

[0023] The second inclined portion of the second guide surface and the portion of the dosage form guide protrusion where the protrusion length increases are inclined to overlap each other in the vertical direction and correspond to each other.

[0024] The lower surface of the connecting portion is inclined outward, and the first inclined portion of the second guide surface is inclined to overlap and correspond to the lower surface of the connecting portion in a vertical direction.

[0025] The rotor unit includes a rotor cone, a first rotor rail connected to the rotor cone and positioned along the outside of the rotor cone, overlapping the first guide surface, a second rotor rail connected to the first rotor rail and positioned along the outside of the first rotor rail, overlapping the second guide surface, and a drive shaft unit located below the rotor cone and inserted into the rotor insertion port, and the first rotor rail and the second rotor rail are each divided into multiple parts by the dosage form induction port.

[0026] There is a step between the first rotor rail and the second rotor rail, and an upper surface of the second rotor rail is spaced downward from an upper surface of the first rotor rail.

[0027] The insertion limiting portion is located adjacent to the boundary line between the first rotor rail and the second rotor rail, and the distance between the lower end of the insertion limiting portion and the upper surface of the first rotor rail is smaller than the width or height of the dosage form.

[0028] The dosage form guide protrusions are located adjacent to the discharge port and outside the first rotor rail, and a lower end of a portion of the dosage form guide protrusions is located below the upper surface of the first rotor rail. The device further includes a cartridge that contains a dosage form therein and is coupled to the housing to allow the dosage form to flow into the interior space of the housing.

[0029] A dispenser according to one example of the present invention includes a plurality of dosage form cartridge assemblies, a plurality of motors connected to drive shafts of the plurality of dosage form cartridge assemblies, and a drive control unit that controls each of the plurality of motors.

[0030] The device further includes a discharge number sensor that senses the number of dosage forms discharged through the discharge ports of each of the plurality of dosage form cartridge assemblies, and the discharge number sensor is located below the discharge ports of each of the plurality of dosage form cartridge assemblies and is connected to the drive control unit. [Effects of the Invention]

[0031] According to this feature, the present invention automatically dispenses the dosage form according to the type and dosage of the dosage form to be taken according to the current physical condition of the user, thereby greatly improving the convenience for the user. [Brief explanation of the drawings]

[0032] [Figure 1a] 1 is a diagram illustrating a dosage form dispenser according to an embodiment of the present invention. [Figure 1b] 1 is a diagram illustrating a dosage form dispenser according to an embodiment of the present invention. [Figure 1c] 1 is a diagram illustrating a dosage form dispenser according to an embodiment of the present invention. [Figure 2]FIG. 1b is a cross-sectional view of the dosage form dispenser shown in FIG. 1a. [Figure 3] 1 is a perspective view of a dosage form dispenser assembly according to one embodiment of the present invention; [Figure 4] FIG. 4 is an exploded perspective view of the dosage form cartridge assembly shown in FIG. 3. [Figure 5] This is a view of the discharge unit shown in FIG. 4 as seen from above. [Figure 6a] FIG. 4 is a view of the housing of the dosage form cartridge assembly shown in FIG. 3. [Figure 6b] FIG. 4 is a view of the housing of the dosage form cartridge assembly shown in FIG. 3. [Figure 6c] FIG. 4 is a view of the housing of the dosage form cartridge assembly shown in FIG. 3. [Figure 6d] FIG. 4 is a view of the housing of the dosage form cartridge assembly shown in FIG. 3. [Figure 7] 1 is a diagram illustrating an example of a portion where a housing and a cartridge are joined in a dosage form dispenser according to an embodiment of the present invention. [Figure 8a] 4 is a diagram for explaining an example of a discharge cap in the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 8b] 4 is a diagram for explaining an example of a discharge cap in the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 8c] 4 is a diagram for explaining an example of a discharge cap in the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 8d] 4 is a diagram for explaining an example of a discharge cap in the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 8e] 4 is a diagram for explaining an example of a discharge cap in the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 9a] 4 is a diagram for explaining an example of a rotor portion in a housing of the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 9b] 4 is a diagram for explaining an example of a rotor portion in a housing of the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 9c] 4 is a diagram for explaining an example of a rotor portion in a housing of the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 9d] 4 is a diagram for explaining an example of a rotor portion in a housing of the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 10a] 4 is a view for explaining a state in which the rotor portion in the dosage form cartridge assembly shown in FIG. 3 is coupled to the discharge cap. FIG. [Figure 10b] 4 is a view for explaining a state in which the rotor portion in the dosage form cartridge assembly shown in FIG. 3 is coupled to the discharge cap. FIG. [Figure 10c] 4 is a view for explaining a state in which the rotor portion in the dosage form cartridge assembly shown in FIG. 3 is coupled to the discharge cap. FIG. [Figure 10d] 4 is a view for explaining a state in which the rotor portion in the dosage form cartridge assembly shown in FIG. 3 is coupled to the discharge cap. FIG. [Figure 11a] 4 is a diagram for explaining the coupling relationship between the housing and the discharge cap in the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 11b] 4 is a diagram for explaining the coupling relationship between the housing and the discharge cap in the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 11c] 4 is a diagram for explaining the coupling relationship between the housing and the discharge cap in the dosage form cartridge assembly shown in FIG. 3. FIG. [Figure 12a] 10A and 10B are diagrams for explaining the coupling relationship between the housing, the rotor, and the discharge cap. [Figure 12b] 10A and 10B are diagrams for explaining the coupling relationship between the housing, the rotor, and the discharge cap. [Figure 12c] 10A and 10B are diagrams for explaining the coupling relationship between the housing, the rotor, and the discharge cap. [Figure 12d] 10A and 10B are diagrams for explaining the coupling relationship between the housing, the rotor, and the discharge cap. [Figure 13] 10A to 10C are views illustrating a process in which a dispensing unit according to an embodiment of the present invention dispenses a dosage form. [Figure 14] 10A to 10C are views illustrating a process in which a dispensing unit according to an embodiment of the present invention dispenses a dosage form. [Figure 15] 10A to 10C are views illustrating a process in which a dispensing unit according to an embodiment of the present invention dispenses a dosage form. [Figure 16] 10A to 10C are views illustrating a process in which a dispensing unit according to an embodiment of the present invention dispenses a dosage form. [Figure 17] 10A to 10C are views illustrating a process in which a dispensing unit according to an embodiment of the present invention dispenses a dosage form. [Figure 18] FIG. 2 is a schematic block diagram of a control unit of a dosage dispenser according to one embodiment of the present invention. [Figure 19a] 1 is an operational flowchart of a dosage form ejection operation in a cartridge control unit of a dosage form dispenser according to an embodiment of the present invention; [Figure 19b] 1 is an operational flowchart of a dosage form ejection operation in a cartridge control unit of a dosage form dispenser according to an embodiment of the present invention; [Figure 20] 10A and 10B are diagrams illustrating another example of a discharge unit according to the present invention. DETAILED DESCRIPTION OF THE INVENTION

[0033] Hereinafter, the embodiments disclosed in the present invention will be described in detail with reference to the accompanying drawings, in which the same or similar components are given the same reference numerals regardless of the drawing numbers, and redundant descriptions thereof will be omitted. Furthermore, in describing the embodiments disclosed in this specification, if it is determined that a detailed description of related publicly known technology may obscure the gist of the embodiments disclosed in this specification, the detailed description thereof will be omitted. Terms including ordinal numbers such as "first," "second," etc. are used to describe various components, but the components are not limited to these terms. The terms are used only to distinguish one component from another. A singular expression includes a plural expression unless the context clearly indicates otherwise. In this application, the steps described are performed without regard to the order in which they are listed, unless a specific causal relationship dictates that the steps be performed in the order listed. In this application, the terms "comprise" or "have" and the like are intended to specify the presence of any feature, number, step, operation, component, part, or combination thereof described above in the specification, but are to be understood as not precluding the possible presence or addition of one or more other features, numbers, steps, operations, components, parts, or combinations thereof. In addition, the following expression "the thickness, width, or length of certain components is the same" means that the thickness, width, or length of a certain first component is within a 10% tolerance range compared to the thickness, width, or length of another second component, taking into account process errors. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, a dosage form cartridge assembly, a dosage form dispenser including the same, and a dosage form cartridge control unit according to an embodiment of the present invention will be described with reference to the accompanying drawings. In this specification, a dosage form refers to a solid form of a health supplement such as a supplement or a medicine that is made to suit the purpose and use of the product, and the dosage form may have a variety of shapes such as a circle, an oval, a cylinder, a polygon, etc. The size of such a dosage form, for example, the maximum diameter or maximum length, is, for example, 1 mm to 7 mm, but is not limited to this, and the size of the dosage form may be changed as necessary. 1a-2, an example of a dosage dispenser including a dosage cartridge assembly according to one embodiment of the present invention will be described. 1a to 1c are diagrams illustrating a dosage form dispenser according to an embodiment of the present invention, in which Fig. 1a is a perspective view of the overall appearance of the dosage form dispenser, Fig. 1b is a perspective view of the dosage form dispenser with its top cover open, and Fig. 1c is a view showing a state in which a dosage form cartridge assembly is separated from a receiving opening of the dosage form dispenser. FIG. 2 shows a vertical cross section of a dosage form dispenser according to one embodiment of the present invention. In this specification, for the sake of convenience, the direction toward the front or rear of the dosage form dispenser 1 based on the dosage form dispenser 1 is referred to as the first direction (x), the direction that intersects the first direction (x) horizontally is referred to as the second direction (y), and the direction that intersects the first direction (x) and the second direction (y) vertically is referred to as the third direction (x). Therefore, taking the dosage form dispenser 1 shown in Figure 1a as a reference, the first direction (x) is the front-to-back direction of the dosage form dispenser 1, the second direction (y) is the left-to-right direction of the dosage form dispenser 1, and the third direction (z) is the height direction of the dosage form dispenser 1. As shown in FIGS. 1a to 1c, an example of a dosage form dispenser 1 according to an embodiment of the present invention includes a storage unit 10, a main body 20, a device terminal 30, and a cradle 40. The storage unit 10 is a part into which a plurality of dosage form cartridge assemblies 60, each containing a dosage form, are inserted and stored, and is located at the rear of the dosage form dispenser 1 along the first direction (x) of the dosage form dispenser 1. The storage unit 10 has, for example, a generally cylindrical shape, is elongated along the third direction (z), and has a circular planar shape. Therefore, the side surfaces of the storage unit 10 have curved surfaces. As shown in Figures 1b and 1c, such a storage unit 10 comprises a housing 11, a storage section 12 located within the internal space surrounded by the housing 11, and an installation status indicator 13 located at the center of the storage section 12 and indicating the installation status of the dosage form cartridge assembly 60 within the storage section 12. The housing 11 includes a case 111 and a heat insulating part 112 attached to the inner surface of the case 111 . The case 111 is for protecting the storage unit 10 and is made of a synthetic material such as plastic or a metal. The shape of such a case 111 is determined depending on the shape of the storage unit 10, and as an example, it has a circular planar shape and a cylindrical shape with open top and bottom. The heat insulating section 112 is for maintaining the internal temperature of the storage unit 10 at a predetermined temperature (for example, 5° C. to 15° C.), and contains a heat insulating material that has a heat insulating effect. The storage section 12 is a portion into which the dosage form cartridge assembly 60 is inserted and attached, and has a plurality of cartridge storage openings H12. In this example, the storage section 12 is made of a synthetic material. Alternatively, the storage compartment 12 may contain insulating material, which may further improve the thermal insulation of the storage unit 10. As shown in FIGS. 1b and 1c, one dosage form cartridge assembly 60 is inserted into each of the plurality of cartridge receiving openings H12, and the cartridge receiving openings H12 are arranged radially around the center of the receiving opening H12. Also, for example, the plurality of cartridge collection holes H12 are arranged in a circle at equal distances from the center, and the intervals between two adjacent cartridge receiving holes H12 are also equal to each other. As a result, when a dosage form is ejected from each cartridge assembly 60 inserted into each of the multiple cartridge storage ports H12, the time it takes for the corresponding dosage form to be ejected from each dosage form cartridge assembly 60 toward the receiving base 40 outside the dosage form dispenser 1 is the same. The shape and size of each cartridge receiving opening H12 are all the same, and the shape and size of each cartridge receiving opening H12 are determined by the planar shape of the dosage form cartridge assembly 60 to be inserted. As shown in FIGS. 1b and 1c, one side of the cartridge receiving opening H12 is provided with a receiving guide opening H121 for guiding the insertion direction of the dosage form cartridge assembly 60. In this case, the storage guide opening H21 has a shape that protrudes toward the center of the cartridge storage opening H12, that is, toward the installation state display part 13. As shown in Figures 1b and 1c, the cartridge storage opening H12 and the storage guide opening H121 are connected to each other and communicate with each other. Therefore, the user can quickly and accurately determine the insertion direction of the dosage form cartridge assembly 60 using the storage guide port H121, allowing for smooth insertion of the dosage form cartridge assembly 60 and increasing user convenience. In Figures 1b and 1c, the number of cartridge storage openings H12 is eight as an example, but this is not limitative and may be changed, and the number of cartridge storage openings H12 may be more or less than eight. As the number of dosage form cartridge assemblies 60 stored in the storage section 12 increases, the number of dosage forms T10 dispensed from the dosage form dispenser 1 per unit time also increases. For example, each dosage form cartridge assembly 60 rapidly dispenses 5 to 10 or more dosage forms per second, and as the number of dosage form cartridge assemblies 60 inserted into the dosage form dispenser 1 increases, the number of dosage forms dispensed per second by the dosage form dispenser 1 also increases. For example, the number of dosage forms T10 dispensed at one time from the dosage form dispenser 1 is between 25 and 250. The installation status display section 13 is located at the center of the storage section 12 and is surrounded by a plurality of cartridge storage openings H12. The installation status indicator 13 has a plurality of light-emitting elements such as light-emitting diodes, and the number of the installation status indicators 13 is the same as the number of the cartridge receiving openings H12, and is electrically connected to a control module (not shown). For the operation of the installation status indicator 13, an installation detector (not shown) is located in each cartridge receiving opening H12 to detect whether the corresponding dosage form cartridge assembly 60 has been installed normally. Therefore, when the corresponding dosage form cartridge assembly 60 is properly attached to each cartridge receiving port H12, the control module outputs a first driving signal to the corresponding light emitting unit corresponding to the cartridge receiving port H12, causing light of a predetermined first color (e.g., green) to be emitted. However, if the dosage form cartridge assembly 60 corresponding to the cartridge receiving port H12 is not properly installed or is empty, the control module outputs a second drive signal to the corresponding light-emitting unit corresponding to the cartridge receiving port H12, causing light of a second color (e.g., red) different from the determined first color to be emitted. This allows the user to visually check the installation state of each dosage form cartridge assembly 60, ensuring that the dosage form cartridge assembly 60 is installed in the correct state. In this example, the lower end of each dosage form cartridge assembly 60, that is, the lower end of the storage unit 10 of the dosage form suspenser 1, remains open to dispense the corresponding dosage form. However, if this open state is left, foreign matter such as dust and moisture may enter the dosage form cartridge assembly 60 from the outside through the open portion, and the inflow of such foreign matter may cause contamination and deterioration of the dosage form cartridge assembly 60 and the dosage forms stored therein. Therefore, as shown in FIG. 2, the storage unit 10 includes a sealing portion 14 that functions as a lid covering the lower end of the opened dosage form dispenser 1, i.e., the lower ends of all the dosage form cartridge assemblies 60, and a sealing portion drive portion 15 that moves the sealing portion 14 up and down along the third direction (z). The sealing section driving section 15 includes a motor and a motor driving circuit that drives the motor. Therefore, while the dosage form is being ejected from the corresponding dosage form cartridge assembly 60, the sealing part driving part 15 is driven to the corresponding state by a drive signal applied from the control module, causing the motor to rotate in a predetermined direction (e.g., clockwise), and this rotation of the motor causes the sealing part 14 to descend to a predetermined position. Therefore, the open lower end of the dosage form cartridge assembly 60 is exposed to the outside by the downward movement of the sealing part 14, and the dosage form is discharged from the dosage form cartridge assembly 60 to the outside. In addition, when the dosage form ejection operation is completed in the dosage form cartridge assembly 60, the sealing unit drive unit 15 is operated by a drive signal applied from the control module, and the motor is rotated in the opposite direction (e.g., counterclockwise) to when the dosage form is ejected. As a result, the sealing portion 14 rises to a predetermined position, in the opposite direction to when discharging, and this rising movement of the sealing portion 14 closes the open lower end of the corresponding dosage form cartridge assembly 60 (see Figure 2). Therefore, the dosage form is normally ejected from the corresponding dosage form cartridge assembly 60 by the raising or lowering operation of the sealing part 14 by the sealing part driving part 15, and the dosage form and dosage form cartridge assembly 60 are protected from external foreign matter. Furthermore, the upper part of the storage unit 20, that is, the upper part of the housing 11, is provided with an upper cover 16 that can be opened and closed by the user. A part of the top cover 16 is hinged to a part of the housing 11 and is opened by the user as shown in FIG. 1b. The main body 20 is positioned so as to be attached to the rear of the dosage form dispenser 1, and is the part where the discharge of the dosage forms housed in each dosage form cartridge assembly 60 is controlled. Such a main body 20 is provided with a refrigeration device for refrigerating the storage section 12 in which the multiple dosage form cartridge assemblies 60 are located, and although not shown in Figure 2, the refrigeration device is provided with a heat dissipation section having at least one of a heat sink and a heat dissipation fan. The heat sink discharges heat generated from the storage unit 10 to the outside. The heat dissipation fan is connected to a control module, and its rotation speed is controlled by a control signal applied from the control module. Therefore, the control module determines the temperature at a corresponding position based on the temperature detection signal applied from the temperature detector, and controls whether to operate the cooling fan and its rotation speed based on the determined temperature. Such a heat dissipation section allows the internal temperature of the storage unit 10 to be maintained at a set temperature, and the dosage forms stored in the storage unit 10 are stored at an appropriate temperature. The device terminal 30 is located at the top of the dosage form dispenser 1. In this case, the device terminal 30 is located across the top of the storage unit 10 and the top of the main body 20, as shown in Figure 1a. The device terminal unit 30 controls the overall operation of the dosage form dispenser 1 and displays menus for setting operations and operations, operation status, etc. Therefore, the device terminal unit 30 of this example includes at least some of the components of the control module that controls the operation of the dosage form dispenser 1, and also includes a display panel that visually outputs data. In this case, the display panel includes a touch panel through which a user can input data. In this example, the dosage form dispenser 1 determines the type of dosage form containing different nutritional components currently required by the user based on real-time physical condition information input by the user via the device terminal unit 30, determines the determined type of dosage form and the dosage of each dosage form (i.e., the number of dispensed), and dispenses the corresponding type of dosage form for the user to take. To this end, the device terminal unit 30 receives information about the user's physical or mental health condition (e.g., fatigue, stress, whether or not exercise is possible, whether or not drinking is possible, premenstrual syndrome, allergic rhinitis, etc.) as current user condition information. The current user status information input via the device terminal 30 is input to a control module (not shown), which then determines the type and amount of dosage to be taken and controls the operation of the dosage form dispenser 1 so that the determined type of dosage form is dispensed in a predetermined quantity. In this way, in the dosage form dispenser 1 of this embodiment, the type and dosage of the dosage form to be currently taken by each user is determined based on the current user condition information. The cradle 40 is located at the bottom of the storage unit 10 and allows the dosage form dispenser 1 to be stably positioned in a predetermined position. An example of a dosage form cartridge assembly 60 that can be attached to the storage unit 10 of the dosage form dispenser 1 will now be described. Figure 3 is a perspective view of a dosage form dispenser assembly according to one embodiment of the present invention, and Figure 4 is an exploded perspective view of the dosage form cartridge assembly shown in Figure 3. Figure 5 is a view of the discharge unit of the dosage form cartridge assembly shown in Figure 3 as seen from above. 6a to 6d are views of the housing of the dosage form cartridge assembly shown in FIG. 3, and FIG. 7 is a view illustrating an example of the part where the housing and cartridge are joined in a dosage form dispenser according to one embodiment of the present invention. The plurality of dosage form cartridge assemblies 60 attached to the storage unit 10 have the same structure. An example of such a dosage form cartridge assembly 60 includes a cartridge 70 containing a dosage form, and a discharge unit 80 coupled to the cartridge 70, as shown in FIG. The multiple cartridges 70 each store a different dosage form T10 containing a different nutritional ingredient (eg, vitamin A, vitamin C, lutein, omega-3, etc.). The hardness of these dosage forms T10 is equal to or greater than a standard value (e.g., 2.4 kp), and is such that they will not be damaged, broken, or otherwise damaged by collisions or impacts during the dispensing operation by the dosage form dispenser 1 of this example. In addition, the dosage form T10 of the present invention has an appropriate maximum width and maximum height, and the ratio of the maximum width to the maximum height is formed within an appropriate range, so that it has a structure that allows it to be easily discharged to the outside through the dosage form dispenser 1 of this example. Since each cartridge 70 is coupled to one discharge unit 80 , the number of discharge units 80 is the same as the number of cartridges 70 housed in the housing section 12 . Therefore, the operation of each dispensing unit 80 can be controlled individually and independently by the control of the control module, and it is determined whether or not the dosage form T10 stored in each cartridge 70 can be dispensed and how many dosage forms T10 can be dispensed. Cartridge 70 has a generally circular cross-sectional shape and has a space therein for accommodating dosage form T10. As shown in FIG. 4, the cartridge 70 includes a cartridge body 71 and a coupling portion 72 for coupling with a discharge unit 80 located below. The cartridge body 71 has an open lower portion coupled to the discharge unit 80 and a closed upper portion opposite the lower portion, and the cartridge body 71 has a cylindrical shape. A removal groove P71 is formed in a circular shape along the outer surface at the top of the cartridge body 71, and this removal groove P71 allows the user to more easily remove the cartridge 70 inserted into the cartridge storage opening H12. The coupling portion 72 located at the bottom of the opened cartridge body 71 is for coupling with the discharge unit 80 as described above. For example, the cartridge 70 and the discharge unit 80 are thermally coupled, so that the threads 721 are located on the outside of the coupling portion 72 . The ejection unit 80 comprises a housing 801 that is connected to the cartridge 70, an ejection cap 802 that is connected to the housing 801 at the bottom of the housing 801, and a rotor part 803 that is located between the ejection cap 802 and the housing 801 and is connected to the ejection cap 802. As shown in FIG. 5, the ejection unit 80 is configured such that the housing 801, the ejection cap 802, and the rotor part 803 are connected to each other, and the rotor part 803 rotates to separate the dosage forms stored in the cartridge 70 and eject them one by one to the outside. In the following, for the sake of convenience, if the rotor part 803 rotates in the direction in which the dosage form T10 is discharged, this rotation direction will be referred to as forward rotation, and if the rotor part 803 rotates in the opposite direction to the forward rotation, this rotation direction will be referred to as reverse rotation. As shown in Figures 6a to 6d, the housing 801 comprises a housing main body 811, a storage guide protrusion 812 (e.g., a first storage guide protrusion) protruding from a portion of the outer side of the housing main body 811, an insertion limiting portion 813 located on the inner surface (i.e., the internal surface) of the housing main body 811, a plurality of blocking ribs (ribs) located on the inner surface (i.e., the internal surface) of the insertion limiting portion 813, and a dosage form guide protrusion 815 attached to the lower end of the insertion limiting portion 813. The housing body 811 forms the outer shape of the housing 801, extends vertically, has a cylindrical empty space in the center in which multiple dosage forms are located, and has a cylindrical shape extending vertically with both the top and bottom facing downward. Here, the vertical direction means a direction perpendicular to the rotation direction of the rotor part 803 . The housing body 811 forms the outer wall of the housing 801, extends vertically, and has a screw thread 8111 on its inner surface for coupling with the cartridge 70 located above. Therefore, the cartridge 70 is screw-coupled to the housing body 811 by the screw threads 711 of the cartridge 70 and the screw threads 8111 of the housing body 811 . The first storage guide protrusion 812 is for guiding the insertion direction of the dosage form cartridge assembly 60 inserted into the corresponding cartridge storage opening H12, and is the part that is inserted into the storage guide opening H121 of the corresponding cartridge storage opening H12. The discharge port H8212 of the discharge cap 802 is located adjacent to the inside of the first storage guide protrusion 812. Therefore, the user can easily determine the position of the discharge port H8212 from the position of the first storage guide protrusion 812. The first storage guide protrusion 812 has a shape corresponding to the shape of the storage guide opening H121 connected to and communicating with the cartridge storage opening H12, and for example has a roughly triangular side shape. Therefore, the user determines the insertion direction of the dosage form cartridge assembly 60 so that the first storage guide protrusion 812 is inserted into the storage guide port H121 of the corresponding cartridge storage port H12, and then inserts the dosage form cartridge assembly 60 into the corresponding cartridge storage port H12. The insertion limiting portion 813 is positioned inside the housing body 811 so as to be spaced apart from the housing body and extends in the vertical direction. The insertion limiting portion 813 spatially and structurally restricts a portion of the outside of the rotor portion 803 within the housing body 811, restricting the remaining dosage forms, excluding the dosage form ejected into the dosage form induction port 834 of the rotor portion 803, from moving outside the rotor portion 803. Therefore, as shown in FIG. 5, when viewed from above the housing body, the outer portion 833 of the rotor portion is hidden by the insertion limiting portion, and the inner portion 832 of the rotor portion 803 is exposed, and the distance between the insertion limiting portion 813 and the inner portion 832 of the rotor portion 803 is formed smaller than the width or height of the dosage form. The insertion limiting portion 813 limits the degree of insertion of the cartridge 70, which is screw-coupled to the housing 801. As shown in Fig. 7, the cartridge 70 is screw-coupled to the housing 801 by rotating in a corresponding direction until its lower end contacts the upper end of the insertion limiting portion 813. Such an insertion limiting portion 813 forms the inner wall of the housing 801 and is positioned at a predetermined distance from the inner surface of the housing main body 811, and is therefore positioned inside the housing main body 811 so as to be separated from the housing main body 811. Therefore, when the cartridge 70 and the housing main body 811 are coupled to each other, the internal space of the cartridge 70 is connected and electrically connected to the internal space surrounded by the insertion limiting portion 813. Due to this spatial connection between the cartridge 70 and the insertion limiting portion 813, the dosage form T10 contained in the cartridge 70 is discharged and positioned in the internal space surrounded by the insertion limiting portion 813 due to its own weight. The insertion limiting portion 813 is positioned to extend along the inner surface of the circular housing body 811, so that the housing body 811 and the insertion limiting portion 813 are positioned to be spaced apart by a predetermined distance as described above. Therefore, the separation space between the housing main body 811 and the insertion limiting portion 813 is closed, and thereby the housing main body 811 and the insertion limiting portion 813 are connected to each other. To this end, the housing 801 includes a connecting portion 8131 that is located between the lower end of the insertion limiting portion 813 and a portion of the housing main body 811 adjacent to the lower end, closes the space between the housing main body 811 and the insertion limiting portion 813, and connects the insertion limiting portion 813 to the housing main body 811. The connecting portion 813 extends outward from the lower end of the insertion limiting portion 813 and is connected to the housing main body 811. Due to the connecting portion 8131, a space with a closed bottom and an open top exists between the insertion limiting portion 813 and the housing main body 811. Therefore, the insertion limiting portion 813 is coupled to the housing main body 811 while maintaining a spacing between the insertion limiting portion 813 and the inner surface of the housing main body 811. As shown in FIG. 6b, the external surface (i.e., the lower surface) of the connecting portion 8131 exposed to the outside has an inclined surface that slopes downward (i.e., the outer lower portion) from the insertion limiting portion 813 toward the housing main body 811. In this example, as shown in FIG. 6b, the height of the upper end of the insertion limiting portion 813 is lower than the height of the upper end of the housing main body 811, and the height of the lower end of the insertion limiting portion 813 is higher than the height of the lower end of the housing main body 811. Therefore, the entire insertion restriction portion 813 is located in the internal space of the housing body 811, and no part of it protrudes outside the housing body 811. A plurality of blocking ribs 814 protrude from the inner surface of the insertion limiting portion 813 at predetermined intervals. The plurality of blocking ribs 814 protrude upward toward the center of the inner space of all the insertion limiting portions 813. In this case, the interval between two adjacent blocking ribs 814 is the same, and the interval between two adjacent blocking ribs 814 decreases from the inner surface of the insertion limiting portion 813 toward the upper center of the inner space. In this way, the blocking rib 814 protruding into the empty internal space of the insertion limiting portion 813 reduces the size of the empty space on the plane of the insertion limiting portion 813 and the empty space above the insertion limiting portion 813 by the amount of the blocking rib 814 located, and also divides it into multiple spaces. In addition, the maximum width D11 of the circular space DC1 formed when connecting the ends of each blocking rib 814 protruding toward the internal space of the insertion limiting portion 813 with an imaginary line is smaller than the maximum width D12 of the internal space of the insertion limiting portion 813. In this case, the size of the maximum width D11 is also determined roughly depending on the protruding length of the blocking rib 814. The cartridge 70 is provided with a dehumidifying cloth containing a dehumidifying agent such as silica gel to reduce the humidity inside the cartridge 70. Such a dehumidifying cloth has a volume much larger than one dosage form T10. Therefore, when the dehumidifying cloth installed inside the cartridge 70 is suddenly ejected outside the cartridge 70 and falls into the internal space surrounded by the insertion limiting section 813, the multiple blocking ribs 814 function as a filter to block the falling dehumidifying agent and prevent it from entering the internal space of the insertion limiting section 813. In this example, the blocking rib 814 has an inclined surface that slopes vertically upward, i.e., toward the cartridge 70 located at the top, but is not limited to this, and may have a flat surface parallel to the installation surface of the dosage form dispenser 1, or an inclined surface that slopes vertically downward, i.e., toward the discharge cap 802. As shown in FIG. 6d, the dosage form guide protrusion 815 attached to protrude downward from the connecting portion 8131 located at the lower end of the insertion limiting portion 813 functions to prevent only the outermost dosage form T11 among the dosage forms T11, T12 located in a row at the discharge position, i.e., the dosage form T11 (e.g., the outermost dosage form) (e.g., the first dosage form) located adjacent to or in contact with the inner surface of the insertion limiting portion 813 from being discharged to the outside, and to prevent the dosage form T12 (e.g., the inner dosage form) (e.g., the second dosage form) located inside the outermost dosage form T11 and further toward the inner space of the insertion limiting portion 813 than the outermost dosage form T11 from being discharged. In addition, the dosage form guide protrusion 815 is provided to protrude from the connecting portion or the insertion limiting portion in the rear direction, and a part of it overlaps with the discharge port. Among the multiple dosage forms seated in the dosage form induction port, a first dosage form located at the outermost edge of the dosage form induction port is separated from a second dosage form located inside the first dosage form. The operation of separating the first dosage form and the second dosage form by the dosage form guide protrusion 815 will be described in detail with reference to Figures 13 to 17. Furthermore, the dosage form guide protrusion 815 prevents the dosage form from being discharged through the dosage form induction port and the discharge port when the rotor unit stops with the dosage form induction port overlapping the discharge port. As shown in Figures 6c and 6d, this dosage form guide protrusion 815 protrudes downward by a predetermined thickness (i.e., protrusion length) from the outer surface of the connecting portion 8131 that forms the lower surface of the housing 801, i.e., a portion of the surface adjacent to the discharge cap 802 as the lower surface. Therefore, the upper surface of the dosage form guide protrusion 815 is integrally formed with the lower surface of the connecting portion 8131 . Referring to Figures 6 to 6d together with Figure 4, the discharge port H8212 is located adjacent to the inside of the first storage guide protrusion 812, and as shown in Figures 6b to 6d, the protruding length and cross-sectional width of the dosage form guide protrusion 815 increase as it approaches the discharge port H8212. As a result, when the rotor part 803 rotates with multiple dosage forms seated in the dosage form guide port 834, the distance between the outermost first dosage form and the inner second dosage form naturally increases due to the dosage form guide protrusion 815, and the first and second dosage forms are separated from each other. As a result, when the dosage form guide port is positioned above the discharge port, the discharge of the second dosage form is blocked by the dosage form guide protrusion 815, and only the first dosage form is discharged through the discharge port H8212. This operation will be described in detail with reference to Figures 13 to 17. As an example, the protruding length of the dosage form guide protrusion 815 increases in a predetermined direction (e.g., the forward rotation direction), and thereby the lower surface of the dosage form guide protrusion 815 is inclined upward along the predetermined direction (e.g., the reverse rotation direction). 6d, the lower end of the dosage form guide protrusion 815 has a structure in which the protruding length is kept constant and increases in the direction of rotation toward the flat first portion 8151 and the discharge port H8212, and the second portion 8152 having an inclined surface is positioned continuously. Here, the first portion 8151 is positioned closer to the discharge port H8121 than the second portion 8152, but overlaps with the discharge port H8212 in the vertical direction. The first portion 8151 has the same thickness (i.e., the protruding length toward the bottom) regardless of position, while the second portion 8152 has a thickness that decreases in the counter-rotation direction. Therefore, the thickness of the first portion 8151 of the dosage form guide protrusion 815 is thicker than the thickness of the second portion 8152. As a result, the protruding length of the starting end S815 of the dosage form guide protrusion 815, which is the tip of the first portion 8151, is longer than the protruding length of the ending end E815 of the dosage form guide protrusion 815, which is the tip of the second portion 8152. Therefore, as shown in Figures 6a and 6d, the protruding length of the dosage form guide protrusion 815 gradually increases in the forward rotation direction. As a result, as described above, the second portion 8152 of the dosage form guide protrusion 815 is an inclined surface whose protruding length gradually decreases toward the terminal end ES815 (see FIGS. 6b and 6d). Due to the difference in the protruding length of the dosage form guide protrusions 815, when the rotor part 803 rotates forward, the outermost dosage form T11 is stably and quickly discharged to the outside. In addition, when the rotor part 803 rotates in the reverse direction, the outermost dosage form T11 comes into contact with the starting end S815 of the first part 8151, which has a relatively large protruding length, preventing the rotor part 803 from rotating in the reverse direction. Therefore, the outermost dosage form T11 is prevented from being discharged during the reverse rotation, and the outermost dosage form T11 is discharged from the top during the forward rotation. In addition, the inner surface of the dosage form guide protrusion 815 (i.e., the surface (e.g., the inner surface) opposite to the outer surface located adjacent to the inner surface of the housing body 811) is also an inclined surface that slopes toward the inner surface of the housing body 811. As a result, the width of the dosage form guide protrusion 815 decreases from the first portion 8151 to the second portion 8152. Such dosage form guide protrusions 815 aid in high speed discharge of the outermost dosage form T11 and prevent or minimize jamming when the dosage form T11 is discharged to the outside. Such dosage form guide protrusions 815 will be described in more detail below. An example structure of the dispensing cap 802 will now be described with reference to Figures 8a to 8e. Figures 8a to 8e are diagrams for explaining an example of a discharge cap of the dosage form cartridge assembly shown in Figure 3. In detail, Figures 8a and 8b are perspective views of the discharge cap, Figure 8c is a vertical cutaway view of the discharge cap, Figure 8d is a top view of the discharge cap to explain the positional relationship between the discharge cap and the dosage form guide protrusion, and Figure 8e is a diagram for explaining the space between the housing and the discharge cap through which the dosage form is moved by the rotor. Incidentally, the rotor is omitted from Figure 8e for ease of understanding. The discharge cap 802 is connected and fixed to the housing 801 to close a part of the open housing body 811, and has a discharge port H8212 on part of the edge through which the dosage form is discharged. As shown in Figures 8a to 8d, such a discharge cap 802 has a cap body 82 with a rotor insertion opening H8211 opened in the center and a discharge opening H8212 on part of the edge, a storage guide protrusion 822 (e.g., a second storage guide protrusion) protruding outward from part of the edge of the cap body 821, and a discharge pipe 823 extending downward from the discharge opening H8212. The cap body 821 includes a rotor insertion opening H8211, a first guide surface S8211, a second guide surface S8212, and a discharge opening H8212. The rotor insertion opening H8211 has a circular opening shape. A part of the rotor unit 803 is inserted into the rotor insertion opening H8211 and is coupled to the rotor unit 803 so as to be rotatable around the rotor insertion opening H8211. A first guide surface S8211 and a second guide surface S8212 are positioned in sequence on the outer side so as to surround the rotor insertion opening H8211 and have an overall circular shape. The first guide surface S8211 surrounds the rotor insertion opening H8211, is provided along the outer periphery of the rotor insertion opening H8211, and is flat with a certain width. A plurality of discharge guide protrusions P821 are located on the flat surface of the first guide surface S8211. The multiple discharge guide protrusions P821 are intended to separate the outermost dosage form T11 located on the second guide surface S8212 from the inner dosage form T12 located on the first guide surface S8211, and to guide only the outermost dosage form T11 to the discharge port H8212. The plurality of discharge guide protrusions P821 are spaced apart by a predetermined distance and are positioned at the boundary between the first guide surface S8211 and the second guide surface S8212 so as to extend a predetermined distance toward the first guide surface S8211. It is not preferable that the discharge guide protrusion P821 is positioned so as to extend up to the second guide surface S8212 in order to couple with the rotor part 803 located above it and to ensure smooth rotation of the rotor part 803. Therefore, the angle (for example, extension angle) of the discharge guide protrusion P821 with the boundary line between the first guide surface S8211 and the second guide surface S8212, that is, the angle θ821 between each discharge guide protrusion P821 adjacent to each boundary point, may vary. In this example, the smallest extension angle θ821 is "0 degrees", and in this case, the discharge guide protrusion P821 having an extension angle θ821 of "0 degrees" is the discharge guide protrusion P821 that is closest to the discharge outlet H8212 among the multiple discharge guide protrusions P821. The average extension angle θ821 of the plurality of discharge guide protrusions P821 is 10 to 50 degrees. In this way, since the multiple discharge guide protrusions P821 are mainly located only on the first guide surface S8211, the rotation of the rotor portion 803 is performed smoothly without being obstructed by the discharge guide protrusions 821. However, the present invention is not necessarily limited to this. The second guide surface S8212 surrounds the first guide surface S8211, is provided with a certain width along the outer periphery of the first guide surface S8211, and includes a portion that is inclined outward from the outer periphery of the first guide surface S8211. The discharge port H8212 is located on an extension of the second guide surface S8212. In this embodiment, the discharge port H8212 is located adjacent to the second storage guide protrusion 822, aligned with the mounting port H2221 in which the storage portion 8221 is located, and facing the opposite side of the mounting port H8221. The storage unit 8221 stores information about the corresponding dosage form cartridge assembly 60 and is made up of a memory chip or the like. For example, the storage unit 8221 stores various information such as the type of dosage form contained in the cartridge assembly 60 to which it is attached, the initial quantity, the manufacturer of the dosage form, and at least one of the expiration date and use-by date of the dosage form. The storage unit 8221 is electrically connected to the control unit and inputs the stored information to the control unit wirelessly or via wire. The second guide surface S8212 includes a first inclined portion G11 and a second inclined portion S12 along the outer circumferential edge of the first guide surface S8211. In this case, the first inclined portion G11 and the second inclined portion G12 are inclined in different directions. As an example, the first inclined portion G11 of the second guide S8212 has an inclined surface that is inclined toward the outside of the cap body 821, and extends in the forward rotation direction from one side of the discharge port H8212 along the outer peripheral edge of the first guide surface S8211. Therefore, the first inclined portion G11 is positioned in contact with one side of the discharge port H8212, and extends in a circular shape from the one side of the discharge port H8212 along the outer periphery of the first guide surface S8211. In addition, the second inclined portion G12 extends from the first inclined portion G11, but has an inclined surface that slopes toward the discharge outlet H212, and extends from the tip of the first inclined portion G11 in the forward rotation direction along the outer peripheral edge of the first guide surface S8211 to contact the other side of the discharge outlet H8212. As a result, the second inclined portion G12 extends in a circular shape from the tip of the first inclined portion G11 along the outer periphery of the first guide surface S8211 and is positioned adjacent to the other side of the discharge port H8212. Therefore, the second inclined portion G12 is located between the discharge port H8212 and the first inclined portion G11, and when the dosage form moved along the first inclined portion G11 is discharged through the discharge port H8212, the second inclined portion G12 allows the dosage form to be discharged more smoothly. Referring to FIG. 8e, the average angle 01 formed between the extension of the first inclined portion G11 and the second inclined portion G12 at the point where the first inclined portion G11 and the second inclined portion G12 meet each other is between 10° and 50°. Also, as shown in FIG. 8e, the second inclined portion G12 of the second guide surface S8212 and the portion 8152 of the dosage form guide protrusion 815 where the protrusion length increases are vertically overlapped with each other and inclined to correspond to each other. For example, the inclined surface of the second inclined portion G12 and the inclined surface of the dosage form guide protrusion 815, that is, the second portion 8152, are inclined in the directions parallel to each other and inclined from top to bottom. The second inclined portion G12 has an inclined surface facing the discharge port H8212, and a step is formed between the second inclined portion G12 and the first guide surface S8211. When the rotor part 803 rotates in the forward direction, the inner part of the ejection position of the rotor part 803, where the outermost dosage form T11 and the inner dosage form T12 are aligned, moves along the first guide surface S8211, and the outer part of the ejection position moves along the first inclined part G11, the second inclined part G12, the other side of the ejection port H8212, the ejection port H8212, one side of the ejection port H8212, and the first inclined part G11. As a result, the outermost dosage form T11 is positioned adjacent to the inner surface of the housing 801 adjacent to the outside of the cap body 821 by the inclined surface of the first inclined portion G11, and the outermost dosage form T11 moved to the second inclined portion G12 is moved more easily and quickly in the direction of the discharge port H8212 by the inclined surface of the second inclined portion G12. As an example, as shown in FIG. 8e, the inclination angle (e.g., first inclination angle) θ11 between the inner surface PG11 (e.g., first side surface) located on one side of the outlet H8212 and the first inclined portion G11 is 85 to 95 degrees, and the inclination angle (e.g., second inclination angle) θ12 between the inner surface PG12 (e.g., second side surface) located on the other side of the outlet H8212 and the second inclined portion G12 is 95 to 175 degrees. In the forward rotation direction, the second inclined portion G12 is positioned so as to come into contact with the discharge port H8212 before the first inclined portion G11. In other words, when viewing the discharge port H8212 from the second insertion guide protrusion 822, the second inclined portion G12 is located on the right side of the discharge port H8212, i.e., so as to be in contact with the forward rotation side of the discharge port H821, which is the direction in which the outermost dosage form T11 is discharged into the discharge port H8212, and the second inclined portion G11 is located on the left side of the discharge port H8212, i.e., so as to be in contact with the reverse rotation side of the discharge port H821, which is the direction in which the outermost dosage form T11 is discharged through the discharge port H8212 into the discharge port H8212. Due to the difference in the inclination angles of the first inclined portion G11 and the second inclined portion G12, the height of the first side surface PG11 where the first inclined portion G11 of the second guide surface S8212 abuts against the discharge port H8212 is higher than the height of the second side surface PG12 where the second inclined portion G12 abuts against the discharge port H8212, as shown in Figures 8a, 8b, and 8. In other words, the height of the second side surface PG12 is lower than the height of the first side surface PG11. The first side surface PG11 and the second side surface PG12 are each located between the adjacent outlet H8122 and second guide surface G8212, and are vertical sides of the second guide surface G8212 that contact the adjacent sides of the outlet H8212, constituting both sides of the second guide surface G8212. The first side surface PG11 is located on the reverse rotation side, which is the left side of the outlet H8212 when viewing the outlet H8212 from the insertion guide protrusion 822 side, and the second side surface PG12 is located on the forward rotation side, which is the right side of the outlet H8212 when viewing the outlet H8212 from the insertion guide protrusion 822 side. Therefore, as described above, when the rotor part 803 rotates in the forward direction, the inclination of the second guide surface S8212 increases due to the second inclined portion G12 as the rotor part 803 approaches the discharge port H8212, so that the outermost dosage form T11 is quickly and safely inserted into the discharge port H8212. As a result, the outermost dosage form T11 collides diagonally with the inner surface of the first side surface PG11 or the inner surface of the discharge pipe 823 and then naturally moves toward the discharge pipe 823, minimizing clogging of the discharge port H8212 by the dosage form T10 even when the rotor part 803 rotates at high speed. The first inclined portion G11 is positioned to correspond to and face the connecting portion 8131 of the housing 801. The inclination direction of the second guide surface S8212 and the inclination direction of the connecting portion 8131 are both inclined toward the outer lower side, so that the outermost dosage form T11 moves safely and accurately toward the discharge port H8212. In addition, since the first side surface PG11 is positioned higher than the second side surface PG12, when the outermost dosage form T11 slides into the discharge port H8212 and is dropped, the outermost dosage form T11 hits the first side surface PG11 located on the opposite side and is discharged safely and smoothly downward. The second storage guide protrusion 822 is positioned corresponding to the first storage guide protrusion 812 of the housing 801 and is coupled with the first storage guide protrusion 812 . As described above, the mounting opening H8221 in which the storage portion 8221 is located is located at the center of the storage guide protrusion 812. The discharge pipe 823 extends downward from the discharge port H8212 and is a guide pipe that guides the dosage form discharged through the discharge port H8212 to the outside. The shape of such a discharge pipe 823 is determined by the shape of the discharge port H8212. In this example, since the discharge port H8212 has a rectangular plane, the discharge port 823 has a rectangular prism shape. A discharge number detector 1022 for detecting the number of dosage forms discharged through the discharge port H8212 is located below the discharge port H8212. For example, the discharge number detector 1022 is located on both sides of the discharge pipe 823 and detects the number of dosage forms transferred through the discharge pipe 823 . For this purpose, the discharge pipe 823 is made of a transparent material such as transparent plastic, and the number of dosage forms T11 passing through the discharge pipe 823 is counted using light from the discharge number sensor 1022. The discharge number sensing unit 1022 of this embodiment is located below the discharge port H8212 and senses the number of dosage forms T10 discharged through the discharge port H8212, and includes a light emitting unit 1022a that emits light and a light receiving unit 1022b that receives light. Therefore, when the dosage form T11 is discharged into the discharge pipe 823, the light receiving part 1022b may be clogged with the discharged dosage form T11 and may not be able to receive the light emitted from the light emitting part 1022a. As a result, the light receiving unit 1022b outputs a signal of the corresponding state to the control unit depending on whether or not it receives the light output from the light emitting unit 1022a, and the control unit determines whether or not it can eject the dosage form T11 depending on whether or not it receives the light using the signal applied from the light receiving unit 1022b. 8b, a light-emitting part 1022a that emits light and a light-receiving part 1022b that receives light are disposed on both sides of the transparent discharge pipe 823, i.e., on opposite sides facing each other. Therefore, the light-receiving part 1022b can receive the light from the light-emitting part 1022a that passes through the transparent discharge pipe 823. Next, the rotor section 803 will be described with reference to Figures 9a to 9d. Figures 9a to 9d are diagrams for explaining an example of a rotor part in the housing of the dosage form cartridge assembly shown in Figure 3. In detail, Figure 9a shows the rotor part as viewed from the upper side, Figure 9b shows the rotor part as viewed from the lower side, Figure 9d shows the rotor part cut vertically, and Figure 9d shows a state in which multiple dosage forms are arranged in a row at the dosage form induction port of the rotor part. 9a is rotatably positioned on the discharge cap 802 and has a dosage form guide port 834 in which the dosage forms to be discharged into the discharge port H8212 are seated. The rotor unit 803 rotates within the housing body 811 and functions to move multiple dosage forms T10 located within the housing body 811 toward the discharge port H8212 of the discharge cap 802 via the dosage form guide port 834. While the rotor unit 803 is a rotor, a plurality of dosage forms T10 located in the internal space of the housing body 811 are seated and loaded into dosage form induction ports 834. The dosage form induction ports 834 extend from the inside to the outside of the rotor unit 803 and have a width and length that allows a plurality of dosage forms, including a first dosage form T11 and a second dosage form T12, to be seated and arranged in a row inside, as shown in Figure 9d. Therefore, the outermost dosage form T11 and the inner dosage form T12 are positioned in a row without overlapping at each dosage form induction port 834 of the rotor unit 803. Next, if the rotor portion 803 continues to rotate in the predetermined direction to eject the outermost dosage form T11 and the inner dosage form T12 positioned at the ejection position, the outermost dosage form T11 and the inner dosage form T12 positioned at the dosage form induction port 834 will also rotate and move in the same direction as the rotation of the rotor portion 803. As the dosage forms T11 and T12 move in this manner, when the outermost dosage form T11, which is located at the outermost edge of the discharge position, comes to be positioned above the discharge port H8212 of the discharge cap 802, this outermost dosage form T11 is dropped into the discharge port H8212 and discharged to the outside along the discharge pipe 823. That is, in this example, the rotor part 803 is inserted into the rotor insertion port H8211 of the discharge cap 802 and coupled with the discharge cap 802, and then, under the control of the control unit, the rotor pushes the outermost dosage form T11 to the discharge port H8212 so that it is discharged to the outside. As shown in Figure 9a, the rotor section 803 has a roughly circular planar shape and includes a rotor cone 831, a first rotor rail 832 connected to the rotor cone 831, a second rotor rail 833 connected to the first rotor rail 832, a plurality of dosage form induction ports 834 located in the first and second rotor rails 832, 833, and a drive shaft section 835 located at the bottom of the rotor cone 831. The rotor cone 831 is located in the center of the rotor part 803, and is inclined outward from the center to protrude toward the position where the cartridge 70 is located. For example, the rotor cone 831 has a gently sloping cone shape. The rotor cone 831 functions to disperse the dosage forms T10 positioned within the inner space of the insertion restricting portion 813 so that the dosage forms T10 do not stick to each other. As shown in Figure 9a, the rotor cone 831, for example, comprises a first surface portion 8311 located in the center, a curved surface portion 8312 (e.g., a second surface portion) connected to a corresponding portion of the first surface portion 8311, having a curved surface and inclined toward the first rotor rail 833, and a flat surface portion 8313 (e.g., a third surface portion) connected to a corresponding portion of the first surface portion 8311, having a flat surface and inclined toward the first rotor rail 833. The first surface portion 8311 has a polygonal planar shape with multiple sides, such as a triangle. The second and third surfaces 8312 and 8313 are alternately positioned around the first surface 8311, and are connected to the corresponding sides of the first surface 8311 alternately. Fukusu dosage form T10 is positioned on a rotor cone 831 including a first surface 8311, a second surface 8312, and a third surface 8313, and a first rotor rail 833. As the rotor cone 831 rotates, the second surface 8312 and the third surface 8313 move alternately while abutting against the dosage forms T10, impacting the dosage forms T10. In such a case, the dosage forms T10 whose surfaces are stuck together among the dosage forms T10 are separated by the impact. The drive shaft 835 is located on the rear surface of the rotor cone and is inserted into the rotor insertion hole H8211 as shown in Fig. 9b. For this purpose, the drive shaft 835 protrudes downward from the rotor part 803, but has a recessed portion on the inside for coupling with the drive shaft of the motor. The first rotor rail 832 is connected to the rotor cone and is positioned along the outside of the rotor cone. More specifically, the first rotor rail 832 is a flat surface that surrounds the rotor cone 831 along the outer circumferential surface of the rotor cone 831, and is positioned on the first guide surface S8211 of the discharge cap 802 so as to overlap with the first guide surface S8211. Therefore, the first rotor rail 832 rotates along the first guide surface S8211. In this case, the width W832 of the first rotor rail 832 is smaller than the width W8211 (see FIG. 8a) of the first guide surface S8211 located at the base. The second rotor rail 833 is connected to the first rotor rail 832 and is positioned along the outer side of the first rotor rail 832 so as to overlap the second guide surface S8212. The second rotor rail 833 has a step in the downward direction of the first rotor rail 832 and is positioned along the outer periphery of the first rotor rail 832 so as to surround the first rotor rail 832 . The width W833 of the second rotor rail 833 is larger than the width W8212 of the second guide surface S8212 located below it, and as an example, the width W8212 of the second guide surface S8212 is larger than the sum of the width of the portion of the first guide surface S8211 that is exposed and not covered by the first rotor rail 832. The width W8212 of the second guide surface S8212, which is an inclined surface, is not the actual width of the second guide surface S8212, which is the width of the inclined surface, but is a virtual width when both ends of the second guide surface S8212 are connected by parallel lines. Therefore, not only the second guide surface S8212 but also a part of the first guide surface S8211 that is not covered by the first rotor rail 832 and is exposed is covered by the second rotor rail 833, and overlaps with the second rotor rail 833. As such, the first rotor rail 832 and the second rotor rail 833 have a stepped structure with a predetermined height, and the upper surface of the second rotor rail 833 is spaced downward from the upper surface of the first rotor rail 832. As described above, the first guide surface S8211 of the rotor cap 802 has a plurality of discharge guide projections P821 positioned toward the upper portion, that is, toward the first rotor rail 832. In order to prevent friction between the lower surface of the second rotor rail 833 and the multiple discharge guide protrusions P821, as shown in Figure 9b, a guide protrusion insertion groove P833 is located on the lower surface of the second rotor rail 833 adjacent to the boundary surface with the first rotor rail 832. Therefore, the discharge guide protrusions P821 protruding upward are inserted into the guide protrusion insertion grooves P833, preventing the discharge guide protrusions P821 from contacting the lower surface of the second rotor rail 833. As a result, the rotor part 803 can rotate smoothly without being obstructed by the discharge guide protrusions P821. A plurality of dosage forms to be discharged as the rotor part 803 rotates are seated and arranged in a line in the dosage form induction port 834. As shown in Figure 9a, each dosage form induction port 834 defines a delivery position for a dosage form T11, T12 waiting to be delivered to the delivery port H8212. As a result, the space surrounded by the dosage form induction port 834, the portion of the discharge cap 802 located below it and exposed by the dosage form induction port 834, that is, a portion of the first guide surface S8211 and a portion of the second guide surface S8212, and the insertion limiting portion 813, becomes the discharge position for the dosage forms T11 and T12. Therefore, as shown in FIG. 9d, the outermost dosage form T11 and the inner dosage form T12 are positioned in a row in the outward direction, that is, along the extension direction of the dosage form induction port 834, without overlapping each other within each dosage form induction port 834. Each dosage form induction port 834 is located continuously from the corresponding tip of the third surface portion 8313 to the first rotor rail 832 and the second rotor rail 833. The dosage form induction port 834 opens a portion of the first rotor rail 832 and the second rotor rail 833, and each of the first rotor rail 832 and the second rotor rail 833 has a structure in which it is divided into a plurality of parts by the dosage form induction port 834. The plurality of first rotor rails 832 have the same structure, and the plurality of second rotor rails 833 also have the same structure. As a result, a portion of the first guide surface S8211 and a portion of the second guide surface S8212 are exposed through the dosage form induction port 834. In addition, when the rotor unit 803 rotates, at least a portion of each dosage form induction port 834 overlaps the discharge port H8212 in the vertical direction, i.e., the height direction, as shown in Figures 10a and 10b. In this example, the number of dosage form induction ports 834 is three, but the present invention is not limited to this, and the number of dosage form induction ports 834 may be more or less than three. As shown in FIGS. 9b and 9d, the first rotor rail 832 and the second rotor rail 833 have side surfaces S832 and S833 extending downwards perpendicular to the installation surface. The side surface S832 of the first rotor rail 832 forms a step structure in which the first rotor rail 832 is connected to the second rotor rail 833 without being interrupted. Furthermore, the side surface S832 of the first rotor rail 832 is positioned in contact with the first guide surface S8212, and the side surface S833 of the second rotor rail 833 is positioned in contact with the second guide surface S8212, so these side surfaces S822, S833 allow the first and second rotor rails 832, 833 to rotate stably on the first and second guide surfaces S8311, S8212, respectively, ensuring stable rotation of the rotor section 803. As shown in FIG. 9d, the lower end of the side surface S833 of the second rotor rail 833 has a flat surface 8331 and an inclined surface 8332. In this case, when viewing the dosage form induction port 834 from the side of the second insertion guide protrusion 822, the inclined surface 8332 is positioned so as to contact the right side of the dosage form induction port 834, that is, the forward rotation side of the dosage form induction port 834, which is the direction in which the outermost dosage form T11 is discharged into the discharge port H8212, and the flat surface 8331 is positioned so as to contact the reverse rotation side of the dosage form induction port 834, which is the left side of the dosage form induction port 834 facing the forward rotation side on the opposite side of the forward rotation side. Therefore, the width (ie, the protruding length) of the side surface S833 having the inclined surface 8332 decreases toward the forward rotation side of the dosage form induction port 834. When the outermost dosage form T11 enters the second inclined portion G12 of the second guide surface S8212 adjacent to the discharge port H8212, the outermost dosage form T11 is subjected to a downward force by the inclined surface 8332 of the second rotor rail 833, allowing the outermost dosage form T11 to enter the discharge port H8212 quickly and accurately. 10a to 10d are views for explaining a state in which the rotor portion of the dosage form cartridge assembly shown in FIG. 3 is coupled to the discharge cap. 10a and 10b, each dosage form induction port 834 through which the outermost dosage form T11 and the inner dosage form T12 are arranged in a line is a hole that is completely open to the top and bottom. As described above, the outermost dosage form T11 and the inner dosage form T12 are arranged in a line within the corresponding dosage form induction port 834 from the rotor cone 831 to the second rotor rail 833 without overlapping. Therefore, each dosage form induction port 834 has a corresponding width W834 (i.e., horizontal length) and a corresponding length L834 (i.e., vertical length) for arranging the outermost dosage form T11 and the inner dosage form T12 in a line. 10a and 10e, dosage forms T10, such as the outermost dosage form T11 and the inner dosage form T12, each have a variety of shapes, such as a cylindrical or spherical shape, and each dosage form T10 has a corresponding width W10 and a corresponding length L10. For example, at least one of the width W10 and length L10 of dosage form T10 is between 3 and 7 mm. Here, the width W10 and length L19 of the dosage form T10 may differ from each other within a predetermined range, as described above. For example, the ratio of the width W10 to the length L10 of the dosage forms T11 and T12 is between 1:0.5 and 1:1.5. The width W834 of the dosage form induction port 834 is larger than at least one of the width W10 and length L10 of the dosage form T10, and in this case, the dosage form induction port 834 has a width that allows one dosage form T10 to be inserted in the width direction of the dosage form induction port 834. For example, the ratio of the width W834 of the dosage form induction port 834 to at least one of the width W10 and length L10 of the dosage form T10 is between 1.1 and 1.5 times. The length L834 of the dosage form induction port 834 is formed to be larger than the width W834 of the dosage form induction port 834, and is formed to be larger than at least one of the width W10 and length L10 of the dosage form T10, and in this case, the outermost dosage form T11 and the inner dosage form T12 are sized to be arranged in a line and loaded. For example, the ratio of the length L834 of the dosage form induction port 834 to the width W834 is between 1.5 and 2.5 times. Also, the ratio of the length L834 of the dosage form induction port 834 to at least one of the width W10 and the length L10 of the dosage form T10 is between 1.5 and 2.5 times. The length L834 of the dosage form induction port 834 is set to a range less than twice the width W10 and length L10 of at least one of the dosage form T10, taking into consideration the distance between the tip of the second rotor rail 833 and the outer surface of the housing main body 811. 10d also shows a height H11 (e.g., a first height) from the upper surface of the first guide surface S8211 exposed by the dosage form induction port 834 to the upper surface of the first rotor rail 832. In this case, the first height H11 has a size that minimizes friction or collision between the dosage forms T11 and T12 positioned in the dosage form induction port 834 and other dosage forms T13 not positioned in the dosage form induction port 834 when the rotor unit 803 rotates. To this end, the first height H11 has a ratio value between 0.8 and 1.2 times that of at least one of the width W10 and the length L10 of the dosage form T10. As described above, the dosage forms T10 are located in the internal space formed by the inner surface of the insertion limiting portion 813, the upper surface of the rotor cone 831 of the rotor portion 803, and the upper surface of the first rotor rail 832 (see FIG. 10c). As described above, when the housing 801 and the discharge cap 802 are coupled, the second rotor rail 833 is mainly located at the connecting portion 8131, and therefore the dosage forms T10 cannot be located on the second rotor rail 833 of the rotor portion 803. In this state, some of the dosage forms T10 become inner dosage forms T12 located in the inner portion of the dosage form induction port 834 where the first guide surface S8211 is exposed, that is, in the portion adjacent to the rotor cone 831. Next, as the rotor part 803 rotates forward, the inner dosage form T12 moves to the outer part of the dosage form induction port 834 where the second guide surface S8212 is exposed, i.e., the part adjacent to the outside on the opposite side of the inner part, thereby making the inner dosage form T12 the outermost dosage form T11 (see Figure 10c). Next, the outermost dosage form T11, which has been moved to the outer portion of the dosage form induction port 834, moves along the second guide surface S8212 due to the continued forward rotation of the rotor part 803, and when the dosage form induction port 834 is positioned above the discharge port H8212, the outermost dosage form T11 also comes to be positioned above the discharge port H8212, and after passing through the discharge port H8212, the outermost dosage form T11 is discharged to the outside through the discharge pipe 823. As a result, due to the rotation of the rotor part 803, each dosage form induction port 834 overlaps with the discharge port H8212 located below, so that the outermost dosage form T11 located at the corresponding dosage form induction port 834 falls into the discharge port H8212. In addition, since the dosage form induction port 834 is a flat surface but is connected to the inclined third surface portion 8313, the dosage form T10 positioned within the corresponding space moves to the corresponding dosage form induction port 834 more quickly and accurately. The drive shaft portion 835 is inserted into the rotor insertion opening H8211 of the discharge cap 802 to rotate the rotor portion 803. To this end, the drive shaft portion 835 has a coupling hole into which the shaft of a drive unit (e.g., a motor) that rotates the rotor portion 803 is inserted, and connection with the drive unit is made through this coupling hole to rotate the rotor portion 803 forward or backward. Therefore, the rotor portion 803 is connected to the discharge cap 802 by the drive shaft portion 835 . When the discharge cap 802 is coupled to the rotor part 803 and then coupled to the housing 801, the open bottom of the insertion limiting part 813 of the housing 801 is closed by the rotor part 802 and the discharge cap 802 exposed by the dosage form induction port 834. As a result, the rotor part 802 and a part of the discharge cap 802 form the bottom surface of the insertion limiting part 813 where the dosage form T10 is located. Furthermore, when the housing body 801 and the discharge cap 802 are coupled together, the first rotor rail 832 is surrounded by the insertion limiting portion 813, and therefore the connecting portion 8131 is located on the second rotor rail 833. Therefore, the plurality of dosage forms T10 discharged from the corresponding cartridge 70 are located on the upper surface of the rotor cone 831 and the upper surface of the first rotor rail 832, and the insertion limiting portion 813 restricts movement toward the second rotor rail 833, so that the dosage forms T10 cannot be located on the second rotor rail 833. The operation of the dosage form cartridge assembly 60 having such a structure will be briefly explained as follows. First, the drive shaft 835 of the rotor part 803 is inserted into the rotor insertion opening H8211 of the discharge cap 802 so that the rotor part 803 is positioned above the discharge cap 802 so as to be rotatable. By connecting the discharge cap 802 and the rotor part 803 in this manner, the first rotor rail 832 of the rotor part 803 becomes rotatable along the first guide surface S8211, and the second rotor rail 833 of the rotor part 803 becomes rotatable along a part of the first guide surface S8211 and the second guide surface S8212. A housing 801 is coupled to the discharge cap 802 to which the rotor portion 802 is coupled. At this time, the person assembling the discharge unit 80 assembles the housing 801 and the discharge cap 802 so that the first storage guide 812 of the housing 801 and the second storage guide 822 of the discharge cap 802 overlap each other. Therefore, the connecting portion 8131 is positioned on the second rotor rail 833, and as a result, the dosage form guide protrusion 815 attached to the lower surface of the connecting portion 8131 is positioned on the second rotor rail 833 so as to overlap with the second rotor rail 833. Therefore, when the rotor part 802 rotates in the forward direction, the end E815 of the dosage form guide projection 815 is positioned in front of the discharge port H8212, and the start end S815 is positioned so as to overlap with the discharge port H8212. In this example, as shown in Figure 6d, the starting end S815 of the dosage form guide protrusion 815 is located at a position more than half the length W8212 (e.g., the length in the rotational direction) extending along the rotational direction of the outlet H8212 and overlaps with the outlet H8212, and the tip E815 is located before the start of the outlet H8212 and does not overlap with the outlet H8212. Therefore, the width W8212 of the discharge port H8212 overlaps with the dosage form guide protrusion 815 by half or more. Due to the positional relationship between the guide protrusion 815 and the discharge port H8212, if the discharge port H8212 and the dosage form induction port 834 do not overlap by a set amount or more, the discharge operation of the outermost dosage form T11 located at the dosage form induction port 834 will not be performed. Figures 11a to 11c are views for explaining the coupling relationship between the housing and the discharge cap in the dosage form cartridge assembly shown in Figure 3. In Figures 11a to 11c, the rotor portion is omitted in order to explain the coupling relationship between the housing and the discharge cap, and Figure 11a shows the housing coupled with the discharge cap as viewed from above, Figure 11b shows a vertical cross section of the housing and the discharge cap so that the cross section of the discharge port is shown, and Figure 11c shows a vertical cross section of a part different from that in Figure 11b. 12a to 12d are cross-sectional views obtained when cutting a dispensing unit according to an embodiment of the present invention along different directions. The insertion limiting portion 813 is positioned vertically adjacent to the boundary surface between the first guide surface S8211 and the second guide surface S8212. As a result, as shown in Figure 11a, when viewed from above the housing 801, the first guide surface is exposed inside the insertion limiting portion 813. 11b and 11c, the second inclined portion G12 of the second guide surface S8212 and the portion 8152 of the dosage form guide protrusion 815 where the protrusion length increases are inclined to overlap each other in the vertical direction and correspond to each other. In addition, at least some of the plurality of discharge guide protrusions P821 are located at a point beyond the terminal end E815 of the dosage form guide protrusion 815. In addition, as shown in Figs. 11b and 11c, the lower surface of the connecting portion 8131 is inclined outward, and the first inclined portion G11 of the second guide surface S8212 is inclined to overlap each other in the vertical direction and correspond to each other. More specifically, the inclination direction of the connecting portion 8131 and the inclination direction of the first inclined portion G11 of the second guide surface S8212 are inclined toward the outer lower side in the same manner. In this case, the inclination of the connecting portion 8131 and the first inclined portion G11 has the same value within a range of approximately 10%. Due to the inclination direction of the connecting portion 8131 and the first inclined portion G11, a passage is formed between the connecting portion 8131 and the first inclined portion G11 through which the outermost dosage form T11 moves when the rotor portion 803 rotates forward. In order to allow smooth movement of the outermost dosage form T11 through the passage, the shortest distance between the connecting portion 8131 and the first inclined portion G11 is greater than 1 time and less than 2 times at least one of the width W10 and length L10 of the dosage form T10. In this way, once the assembly of the ejection unit 80 is completed, the cartridge 70 containing the dosage form 20 is connected to the ejection unit 80 by a screw connection utilizing the threads 721 of the connecting portion 72 of the cartridge 70 and the threads 8111 of the housing body 811, thereby completing the assembly of the dosage form cartridge assembly 60. At this time, the cartridge 70 is assembled with the stopper blocking the inlet removed, so that the multiple dosage forms T10 stored in the cartridge 70 flow into the discharge unit 80 located at the bottom through the open inlet, and are discharged one by one to the outside as the rotor part 803 rotates. As a result, multiple dosage forms T10 ejected from cartridge 70 are positioned within the internal space of insertion limiting portion 813, the lower portion of which is blocked by ejection cap 802 and rotor portion 803, and the outermost dosage form T11 and inner dosage form T12 arranged in a row are also positioned within each dosage form induction port 834 located in rotor portion 803. In order to eject the dosage form, when the rotor portion 803 rotates forward by the operation of the control unit, the dosage form T10 moves outward within the internal space of the insertion limiting portion 813 due to centrifugal force, and the outermost dosage form T11 and the inner dosage form T12 are positioned consecutively in each dosage form induction port 834. In this example, the rotation speed of the rotor section 803 is 50 rpm to 150 rpm. If the rotation speed of the rotor portion 803 is 50 rpm or higher, the discharge speed of the dosage form T10 is stably maintained at the set speed, allowing the dosage form T10 to move and be discharged smoothly; if the rotation speed of the rotor portion 803 is 150 rpm or lower, damage to the dosage form T10 due to excessive speed of the rotor portion 803 is prevented, and the dosage form T10 is discharged smoothly into the discharge port H8212. At least one of the width W10 and length L10 of the dosage form T11 located on the second guide surface S8212 is greater than the distance between the upper surface of the second guide surface S8212 and the upper surface of the second rotor rail 833, and the dosage form T11 protrudes above the upper surface of the second rotor rail 833. Therefore, when the rotor unit 803 rotates forward, the dosage form T11 is pushed in the corresponding direction by the forward-rotating rotor unit 803, and the dosage form T11 rotates smoothly in the forward direction. The outermost dosage form T11 and the inner dosage form T12 rotate in a circular manner along the discharge cap 802, the second guide surface S8212, and the first guide surface S8211 located below, respectively. When the outermost dosage form T11 moves along the second guide surface 8212, the space formed by the first inclined portion G11 of the second guide surface 8212 and the connecting portion 8131 of the housing main body 811 located at the top is the first movement path, and the space formed by the second inclined portion G12 of the second guide surface 8212 and the second portion 8152, which is the inclined surface of the dosage form guide protrusion 815, is the second movement path. As shown in Figure 12a, when the dosage form induction port 834 of the rotor part 803 is positioned above the first and second guide surfaces S8211, S8212 of the discharge cap 802 without overlapping with the discharge port H8212, the centrifugal force caused by the rotation of the rotor part 803 causes the inner dosage form T12, with the dosage form induction port 834 located inside, to move outward, move to the first moving passage, and become the outermost dosage form T11. 12a to 12d, the insertion limiting portion 813 is located adjacent to the boundary between the first rotor rail 832 and the second rotor rail 833, but the distance between the lower end of the insertion limiting portion 813 and the upper surface of the first rotor rail 832 is smaller than the width or height of the dosage form. Therefore, as shown in Fig. 12a, the dosage form located on the first rotor rail 832 is confined in the internal space by the insertion limiting portion 813 and cannot move to the first connecting passage, which is the space formed by the connecting portion 8131 of the housing and the second guide surface S8212 of the discharge cap 802, without passing through the dosage form induction port 834. Also, as shown in FIG. 12b, the dosage form guide protrusion 815 is located adjacent to the discharge port H8212 and outside the first rotor rail, but the lower end of a portion of the dosage form guide protrusion 815 is located below the upper surface of the first rotor rail 832. Furthermore, the distance Dt between the lower end of the portion of the dosage form guide projection 815 that overlaps with the discharge port H8212 and the first guide surface is smaller than the width or height of the dosage forms T11 and T12. As a result, as shown in Figure 12c, when the dosage form induction port 834 is positioned above the discharge port H8212, the outermost dosage form T11 located in the space between the connecting part 8131 of the housing and the second guide surface S8212 of the discharge cap 802 is dropped into the discharge port H8212, but the inner dosage form T12 is blocked by the dosage form guide protrusion 815 located at the top and is not dropped into the discharge port H8212. Additionally, the dosage form guide protrusion 815 is positioned to overlap the upper portion of the second rotor rail 833, and the distance between the upper surface of the second rotor rail 833 and the lower surface of the dosage form guide protrusion 815 is smaller than the width W10 or length L10 of the dosage form T12. Therefore, the dosage form T12 positioned on the first rotor rail 832 is blocked by the dosage form guide protrusion 815 and cannot move to the second rotor rail 833. Also, as shown in Figure 12d, when the dosage form guide port 834 overlaps with the discharge port H8212 and the outermost dosage form T11 is dropped, the inner dosage form T12 is blocked by the dosage form guide protrusion 815 and is not dropped into the discharge port H8212. The dosage form T13 located on the first rotor rail 832 of the rotor part 803 is blocked from moving outward by the inner surface of the housing body 811, thereby preventing the dosage form T13 from flowing into the first connecting passage. Next, the ejection process of dosage form T10 will be described with reference to FIGS. 13 to 17 are views illustrating a process in which a dispensing unit according to an embodiment of the present invention dispenses a dosage form. 13 to 17, (a) shows the discharge cap 802 as viewed from above, with the positions of the dosage form induction port 834 and the dosage form guide protrusion 815 shown imaginarily, and (b) shows a cross section of the housing 801, rotor unit 803, and discharge cap 802 along the first movement path along which the dosage form moves. In detail, (b) shows the space formed by the first inclined portion G11 of the second guide surface 8212 and the connecting portion 8131 of the housing main body 811 located at the top as the first movement path, and the space formed by the second rotor rail 833, the second inclined portion G12 of the second guide surface 8212, and the second portion 8152 which is the inclined surface of the dosage form guide protrusion 815 as the second movement path. As shown in (a) and (b) of Figure 13, when the rotor part 803 rotates forward with the dosage form induction port 834 positioned in a row with the outermost dosage form T11 and the inner dosage form T12, the inner dosage form T12 moves along the first guide surface S8211, and the outermost dosage form T11 moves along the first moving path formed by the second guide surface S8212 and the connecting part 8131. In this case, there is no physical structure between the outermost dosage form T11 and the inner dosage form T12 arranged in a row, and the outermost dosage form T11 and the inner dosage form T12 are in contact with each other. Next, as shown in (a) of Figure 14, if the rotor part 803 continues to rotate forward, the dosage form induction port 834 of the corresponding order among the multiple dosage form induction ports 834 will come into contact with the multiple discharge guide protrusions P821 of the discharge cap 802 and sequentially pass through the discharge guide protrusions P821 arranged in a row. Therefore, the plurality of discharge guide protrusions P821 are sequentially positioned between the inner dosage form T12 and the outermost dosage form T11, and physical separation of the two dosage forms 12, 11 within the corresponding dosage form induction port 834 begins. As a result, the inner dosage form T12 moves inside the discharge cap 802, i.e., toward the rotor insertion port H8211, with the discharge guide protrusion P821 sandwiched therebetween, and the outermost dosage form T11 is separated outside, i.e., outside the insertion limiting portion 813. Next, as shown in (a) of Figure 15, as the rotor part 803 continues to rotate in the forward direction, the dosage form induction port 834 passes under the dosage form guide protrusion 815, and the outermost dosage form T11 and the inner dosage form T12 are completely spatially separated and spaced apart by the dosage form guide protrusion 815. At this time, the inner dosage form T12 is supported inwardly by the dosage form guide protrusion 815 and continues to move along the first guide surface S8211, and the outermost dosage form T11 moves along the lower end of the dosage form guide protrusion 815. More specifically, as shown in (b) of Figure 15, the outermost dosage form T11 is forcibly moved diagonally toward the discharge port H8212 along the second movement path formed by the second inclined portion G12 of the second guide surface S8212 and the second portion 8152, which is the lower inclined surface of the dosage form guide protrusion 815. As the outermost dosage form T11 descends diagonally along the second moving path, a portion of the empty space is formed in the dosage form induction port 834 that was located at the outermost dosage form T11, and the inner dosage form T12 is pushed outward due to the centrifugal force caused by the rotation of the rotor part 803. However, the dosage form guide protrusion 815 of the present invention prevents the inner dosage form T12 from being pushed outward from the dosage form induction port 834. Therefore, even if the outermost dosage form T11 descends obliquely along the second moving path, the inner dosage form T12 continues to be positioned inside the dosage form induction port 834 (ie, above the first guide surface S811). 16(a) and 16(b), as the rotor part 803 continues to rotate in the forward direction, the corresponding dosage form induction port 834 overlaps with the discharge port H8212 of the discharge cap 802, and the outermost dosage form T11 moves into the discharge port H8212 and is discharged to the outside along the discharge pipe 823. At this time, the discharged outermost dosage form T11 naturally moves downward along the discharge pipe 823 while colliding diagonally with at least one inner wall of the discharge port H8212 and the discharge pipe 823. In this way, the second moving passage allows the outermost dosage form T11 to enter the discharge pipe 823 in a diagonal direction, preventing multiple dosage forms T10 from blocking the discharge pipe H8212 (jam) even when the rotor part 803 rotates at a relatively high speed. When the outermost dosage form T11 is dropped into the discharge port H8212, the inner dosage form T12 located on the first guide surface S8211 in the dosage form guide port 834 is blocked from moving toward the discharge port H8212 by the dosage form guide protrusion 815, as shown in (a) of Figure 16, and therefore the inner dosage form T12 is not dropped into the discharge port H8212 and is not discharged to the outside. To prevent such ejection of the inner dosage form T12, the vertical distance Dt (Figure 12d) between the dosage form guide protrusion 815 (more specifically, the lower surface of the dosage form guide protrusion 815) and the upper surface of the first guide surface S8211 is smaller than the width W10 or length L10 of the dosage form T10, as described above. As a result, every time each dosage form induction port 834 overlaps with the discharge port H8212, only one dosage form T11 (ie, the outermost dosage form) is normally dropped into the discharge port H8212 and discharged to the outside. Next, after the outermost dosage form T11 is dropped, the forward rotation of the rotor part 803 causes the dosage form induction port 834 to pass through the discharge port H8212 as shown in (a) and (b) of Figure 17, and at the point where the rotor part 803 passes the end E815 of the dosage form guide protrusion 815, the inner dosage form T12 is pushed to the outermost side of the dosage form induction port 834 by centrifugal force and positioned in the first moving passage, and other dosage forms T13 located near the dosage form induction port 834 flow into the corresponding dosage form induction port 834. Next, a control unit for controlling the operation of the dosage form dispenser 1 of this example will be described with reference to FIG. As shown in FIG. 18, the control unit 100 comprises a terminal control unit 101 located in the device terminal section 30 and a dosage form cartridge control unit 102 located in each dosage form cartridge assembly 60, and the terminal control unit 101 and the dosage form cartridge control unit 102 communicate with each other to send and receive necessary information, etc. The terminal control unit 101 comprises a communication unit 1011, a user input unit 1012, an installation detection unit 1013, a temperature detection unit 1014, an operation control unit 1015 connected to these units 1011-1014, a storage unit 1016 connected to the operation control unit 1015, an information output unit 1017 connected to the operation control unit 1015, an installation status display unit 13 connected to the operation control unit 1015, a heat dissipation fan drive unit 1018 connected to the operation control unit 1015, and a sealing unit drive unit 15 connected to the operation control unit 1015. In addition, the dosage form cartridge control unit 102 includes a communication unit 1021, an ejection number detection unit 1022, a drive control unit 1023 connected to the communication unit 1021 and the ejection number detection unit 1022, a storage unit 1024 connected to the drive control unit 1023, and a rotor unit drive unit 1025 connected to the drive control unit 1023. In the terminal control unit 101, the communication section 1011 is for communication between the dosage form cartridge control units 102 and for communication with an external device such as a server, and includes a wired or wireless communication module. The communication unit 1011 includes at least one of a short-range wireless communication module such as Wi-Fi or ZigBee and an Internet communication module, for example. The user input unit 1012 is used to input data and commands required for the operation of the dosage form dispenser 1, and is a touch panel or operation switch. The information input to the terminal control unit 101 via the user input unit 1012 is at least one of the user's current health condition (e.g., information about physical and mental condition) and information about the user's body (e.g., at least one of age, sex, medical history, and occupation). As described above, the installation detection unit 1013 detects the state of each cartridge storage port H12 to detect whether the dosage form cartridge assembly 60 is properly installed in the corresponding cartridge storage port H12, and outputs an installation detection signal indicating the corresponding state. Thereby, the operation control unit 1015 controls the operation of the installation state display unit 13 according to the state of each receiving opening H12 determined by the signal applied to the installation detection unit 1013. The temperature sensor 1014 senses the temperature inside the storage compartment 12 or the housing 11 to control the rotation speed of the heat dissipation fan, and outputs a temperature sensing signal of a corresponding state to the operation controller 1015 . Accordingly, the operation control unit 1015 controls the operation of the heat dissipation fan driving unit 1018, and controls whether or not the heat dissipation fan is rotated and the rotation speed. The operation control unit 1015 is a control module and a processor that controls the overall operation of the dosage form dispenser 1 using input or transmitted signals. As an example, the operation control unit 1015 determines the type and number of dosage forms T10 to be dispensed from the dosage form dispenser 1 using a signal transmitted from the server via the communication unit 1011, and transmits the determined type and number of dosage forms T10 to the dosage form cartridge control unit 102. As a result, the dosage form cartridge control unit 102 controls the operation of the dosage form cartridge assembly 60 that contains the determined type of dosage form T10 among the multiple dosage form cartridge assemblies 60, so that the determined number of dosage forms T10 are ejected. The storage unit 1016 stores data necessary for the operation of the terminal control unit 101, a driving program, data generated during operation, etc. The storage unit 1016 is a memory. The information output unit 1017 outputs visual information under the control of the operation control unit 1015, and is a flat display panel such as a liquid crystal display panel or an organic light emitting display panel. The information output unit 1017 is a display panel equipped with a touch panel. Therefore, the user can use the information output through the information output unit 1017 to check the information of the user currently using the dosage form dispenser 1, the type of dosage form T10 to be dispensed, and the number of dosage forms T10 to be dispensed, thereby ensuring that the correct dosage of dosage form T10 is provided to the correct user. In addition, the information output unit 1017 displays information about each user currently using the dosage form dispenser 1 (e.g., name and user image (e.g., photo)), the current status of each dosage form cartridge assembly 50, for example, the type and remaining amount (%) of dosage form T10 contained in each dosage form cartridge assembly 60, a selection screen for the user's current physical condition (e.g., fatigue, stomatitis, allergic rhinitis, binge drinking, overtime work, after exercise, etc.) for dispensing the savings, and the results of the nutritional ingredients combined after determining the physical condition. As described above, the installation status display unit 13 changes its operating state in response to a signal output from the installation detection unit 1013, and displays whether or not a dosage form cartridge assembly 60 is installed in each storage opening H12. The attachment state display unit 13 includes a plurality of light emitting units such as light emitting diodes that output light of different hues (for example, a first hue and a second hue). Therefore, if the dosage form cartridge assembly 60 is properly installed in the corresponding storage opening H12, the light emitting part of the first color is lit, whereas if the dosage form cartridge assembly 60 is not properly installed in the corresponding storage opening H12 or is empty, the light emitting part of the second color is lit. The number of the light emitting parts of the first color and the light emitting parts of the second color are each equal to the number of the storage openings H12. The heat dissipation fan driving unit 1018 is for driving the heat dissipation fan, and the sealed part driving unit 15 is for driving the sealed part 14, and each includes a motor and a motor driving circuit for driving the corresponding motor. Therefore, the operation control unit 1015 outputs a control signal of a corresponding state to the heat radiation fan driving unit 1018 according to the temperature determined by the temperature detection signal applied from the temperature detection unit 1014, thereby controlling whether or not the heat radiation fan is to rotate and the rotation state. In addition, when the operation of the dosage form dispenser 1 to dispense a dosage form suitable for the user is started using an operation start signal or the like applied via the user input unit 1012, the operation control unit 1015 outputs a control signal indicating the corresponding state to the sealing unit drive unit 15 to lower the sealing unit 14, thereby allowing the dosage form T10 to be dispensed from the dosage form dispenser 1. On the other hand, if it is determined that the ejection operation of the corresponding dosage form T10 has been completed, the operation control unit 1015 outputs a control signal indicating the corresponding state to the sealing unit driving unit 15 to raise the sealing unit 14, thereby closing the lower end of the opened dosage form dispenser 1 and protecting the attached dosage form cartridge assembly 60 from external foreign matter. At this time, the operation control unit 1015 judges the operation end signal applied from the user input unit 1012 and the operating status of each dosage form cartridge assembly 60, and determines whether the ejection operation of the dosage form T10 suitable for the user has been completed. Next, the dosage form cartridge control unit 102 will be described. The communication unit 1012 of the dosage form cartridge control unit 102 also communicates with the terminal control unit 101 and also communicates with external devices such as a server, and is equipped with at least one of a short-range wireless communication module and an Internet communication module. The ejection number sensing unit 1022 counts the number of dosage forms T10 ejected through the ejection port H8212, and outputs an ejection number sensing signal of a corresponding state depending on whether the dosage form is ejected to the ejection port H8212 or not, and outputs it to the control unit. The discharge number sensing unit 1022 uses, for example, an optical sensor having a light emitting unit 1022a and a light receiving unit 1022b, such as a light emitting diode and a light receiving diode. Therefore, the driving control unit 1023 determines the number of dosage forms T10 currently dispensed using the dispensed number sensing signal applied from the light receiving unit 1022b of the dispensed number sensing unit 1022. The drive control unit 1023 is a control module that controls the overall operation of the dosage form cartridge control unit 102, and is also a processor. The storage unit 8821 is a storage medium such as a memory that stores information about the corresponding dosage form cartridge assembly 60. As described above, the storage section 8821 attached to each cartridge assembly 60 stores at least one of the type of dosage form T10 contained in the dosage form cartridge assembly 60 to which it is attached, the initial number, the number of dosage forms currently being ejected to the outside, and the expiration date and usage period of the dosage form cartridge assembly 60. The rotor section drive section 1025 controls the rotational operation of the rotor section 803, and similarly includes a motor and a motor drive circuit that drives the motor. Therefore, since the drive shaft 835 of the rotor part 803 is connected to the drive shaft of the motor, the rotor part drive part 1025 operates under the control of the drive control part 1023, and rotates the rotor part 803 connected to the motor forward or backward. Next, the dosage form ejection operation of the dosage form cartridge control unit 102 having such a structure will be described with reference to Figures 19a and 19b. First, when the power required for the operation of the dosage form cartridge control unit 102 is supplied and the operation of the dosage form cartridge control unit 102 starts, the operation of the drive control unit 1023 also starts (S10). Therefore, the drive control unit 1023 reads the rotor unit drive information from the storage unit 1024 and determines the number of forward rotations of the rotor unit 803 (S11). In this example, the rotor unit driving information is determined by the current user, and includes, for example, the type of dosage form T10 to be taken according to the user's current health condition and the dosage of that type (i.e., the number of dispensed pieces). Therefore, if the dosage form T10 stored in the dosage form cartridge assembly 60 to which the drive control unit 1023 is attached belongs to the dosage form T10 currently being ejected, the drive control unit 1023 calculates the number of forward rotations of the rotor unit 803 according to the dosage of the corresponding type. In this example, three dosage forms T10 are discharged per forward rotation, so the drive control unit 1023 calculates the number of forward rotations of the rotor unit 803 depending on the dosage. When the forward rotation speed of the corresponding rotor unit 803 is determined, the drive control unit 1023 outputs a forward rotation drive signal to the rotor unit drive unit 1025 for a forward rotation time (e.g., a first forward rotation time) corresponding to the determined forward rotation speed (S12), causing the rotor unit 803 to rotate forward so that the corresponding dosage form T10 is ejected. In this example, the rotation speed of the rotor unit 803 is already fixed, so once the forward rotation number and reverse rotation number are determined, the corresponding reverse rotation time and forward rotation time can be easily calculated. When the forward rotation of the rotor unit 803 is started in this manner, the drive control unit 1023 reads the ejection number detection signal applied from the ejection number detection unit 1022, calculates the current ejection number of the corresponding type of dosage form T10, and then stores it in the storage unit 1024 (S13). This calculation of the current number of ejected droplets continues while the rotor unit 803 rotates in the forward direction. Next, if the output of the forward rotation drive signal is completed within the time corresponding to the determined number of forward rotations (S14), the operation control unit 1015 determines whether the current number of dispensed pieces stored in the storage unit 1024, i.e., the total number of the corresponding type of dosage form T10 dispensed within the corresponding time, is the same as the set number (S15). At this time, the set number is determined based on the dosage of the corresponding type of dosage form T10 and is stored in the storage unit 1204. If the current number of dispensed pieces is the same as the set number (S15), the drive control unit 1023 determines that the corresponding type of dosage form T10 has been dispensed in the normal dose. Therefore, the drive control unit 1023 resets the corresponding current number of dispensed pieces to "0" (S16) and then proceeds to return step S100. However, if the current number of dispensed pieces does not reach the set number, S15 is performed, i.e., if the prescribed amount of the dosage form T10 of the corresponding type has not been dispensed, the drive control unit 1023 determines that the dosage form is not being dispensed smoothly due to clogging of the discharge port H8212 or multiple dosage forms T10 being positioned overlapping each other. Therefore, the drive control unit 1023 rotates the rotor unit 803 in the reverse direction for a predetermined time, and then rotates it in the forward direction again so that the missing number of dosage forms are ejected. To this end, in step S17, the drive control unit 1023 reads the number of reverse rotations of the rotor unit 803 using the data stored in the storage unit 1024, and calculates the reverse rotation time of the rotor unit 803. In this example, the number of reverse rotations for one reverse rotation control is determined in advance. In this example, the reverse rotation time for one reverse rotation control is calculated using the number of reverse rotations. However, in an alternative example, the reverse rotation time for one reverse rotation control may be stored directly in the storage unit 1024. Next, the drive control unit 1023 outputs a control signal of the corresponding state to the rotor unit 803 during the reverse rotation time for the corresponding reverse rotation control in order to perform reverse rotation of the rotor unit 803 during the reverse rotation time for the corresponding reverse rotation control (S18). At this time, the drive control unit 1023 increments the reverse rotation control count (initial value=0) by "1" and stores the incremented count in the storage unit 1024 (S18). Therefore, the rotor unit 803 performs reverse rotation during the reverse rotation time determined by the control of the rotor unit drive unit 1025 . During reverse rotation of the rotor part 803, at least one of the multiple dosage form induction ports 834 has the outermost dosage form T11 present in it, and even if this dosage form induction port 834 overlaps with the discharge port H8212, the outermost dosage form T11 is not dropped into the discharge port H8212. That is, the outermost dosage form T11 present in the dosage form induction port 834 protrudes onto the upper surface of the second rotor rail 833 surrounding the dosage form induction port 834. Therefore, the dosage form guide port 834 blocks a part of the discharge port H8212 that overlaps with the part of the discharge port H8212, and the protruding part of the outermost dosage form T11 may come into contact with the starting end E815 of the dosage form guide protrusion 815, hindering normal reverse rotation. Therefore, when the outermost dosage form T11 comes into contact with the starting end S815 of the dosage form guide protrusion 815, the rotor part 803 cannot rotate in the reverse direction any further. Because the reverse rotation of the rotor part 803 is stopped in this manner, the discharge port H8212 is not opened to the extent that the outermost dosage form T11 is discharged, and therefore, even if a reverse rotation drive signal is output to the rotor part drive part 1025, the discharge of the outermost dosage form T11 and the actual reverse rotation of the rotor part 803 are temporarily interrupted. Therefore, when the rotor part 803 rotates in the reverse direction, the outermost dosage form T11 is not discharged, and only when the rotor part 803 rotates in the forward direction, the outermost dosage form T11 is normally discharged. In this way, after the reverse rotation drive signal is output for the determined reverse rotation time, the drive control unit 1023 further determines the correct score of the rotor unit 803 and calculates the forward rotation time (i.e., the second forward rotation time), and then outputs the forward rotation drive signal to the rotor unit drive unit 1025 for the calculated forward rotation time. At this time, the number of forward rotations of the rotor unit 803 is determined by the number calculated by subtracting the current number of dispensed doses from the set number, i.e., the number of dosage forms to be dispensed. Therefore, the second forward rotation time is shorter than the first forward rotation time. In step S19, after outputting a forward rotation drive signal to the rotor unit driver 1025 to additionally dispense the missing dosage form, the drive control unit 1023 reads the dispensed number detection signal applied from the dispensed number detection unit 1022 to determine whether the outermost dosage form T11 has been dispensed, and calculates the current total number of dispensed dosage forms and stores it in the storage unit 1024 (S110). At this time, the current total number of dispensed dosage forms is the total number of corresponding dosage forms T10 dispensed during the total forward rotation time (e.g., first forward rotation time + second forward rotation time) after the dosage form dispensing operation has been completed. Next, after the rotor unit 803 has rotated forward for the forward rotation time determined in step S19 (S111), the drive control unit 1023 determines whether the current total number of ejections stored in the storage unit 1204 has reached the set number (S112). If the current total number of dispensed units is the same as the set number (S112), the drive control unit 1023 determines that the dosage form T10 of the corresponding type has been dispensed normally in the prescribed dose, resets the current total number of dispensed units to "0", and then proceeds to S113 and return step S100. However, if the current total number of ejected pieces does not reach the set number, S112 is performed, that is, if the missing number of dosage forms is not being ejected normally, the drive control unit 1023 determines whether the current number of reverse rotation controls has reached the set number, S114. Since the current number of reverse rotation control times is the total number of times that the reverse rotation drive signal has been output since the first forward rotation drive signal was output, the drive control unit 1023 increments the current number of reverse rotation control times by "1" each time the reverse rotation control is completed. Therefore, if the current number of reverse rotation control times has not reached the set number of times (S114), the drive control unit 1023 proceeds to step S17 and controls the reverse rotation operation of the rotor unit 803 for the next (e.g., second) number of reverse rotation control times. However, if the current number of reverse rotation controls has reached the set number of times, in S114, the drive control unit 1023 determines that the dosage form cartridge assembly 60 is currently not ejecting the dosage form normally due to a clogging phenomenon or the like. Therefore, the drive control unit 1023 reads the error message stored in the storage unit 1024 and transmits and outputs it to the terminal control unit 101 via the communication unit 1021 (S115). Thereby, the operation control section 1015 of the terminal control unit 101 receives the error message of the dosage form cartridge control unit 102 transmitted via the communication section 1011 and then outputs it to the information output section 1017 . Therefore, the user can use the error message output to the information output unit 1017 to recognize which dosage form cartridge assembly 60 is currently not ejecting the correct dosage form, and then check the condition of the corresponding dosage form cartridge assembly 60 and clean the ejection port H8212, etc. In an alternative example, the dosage form cartridge control unit 102 includes a separate information output unit connected to the drive control unit 1023, and in this case, the drive control unit 1023 outputs the error message directly to the information output unit. Therefore, if the corresponding type of dosage form T10 has not been ejected in the specified dose, the drive control unit 1023 causes the rotor unit 803 to repeat reverse and forward rotation operations a specified number of times, thereby allowing additional ejection of the corresponding dosage form T10. FIG. 20 is a diagram for explaining another example of the discharge unit according to the present invention. In Figure 20, the same parts as those described above will be omitted, and the explanation will focus on other parts. 13 to 17, the case has been described in which the second inclined portion G12 of the second guide surface 8212 and the second portion 8152, which is the inclined surface of the dosage form guide protrusion 815, are formed on one side of the discharge port H8212 in the discharge unit. However, the present invention is not limited to this. As shown in FIG. 20, the discharge unit according to the present invention includes second inclined portions G12 and G12' of the second guide surface 8212 and second portions 8152 and 8152' which are inclined surfaces of the dosage form guide protrusion 815 on both sides of the discharge port H8212. This allows the ink to be discharged from the discharge port H8212 regardless of the direction of rotation of the rotor portion 803. Figure 20 shows an example in which the inclination angles of the second inclined portions G12, G12' of the second guide surface 8212 and the second portions 8152, 8152', which are the inclined surfaces of the dosage form guide protrusion 815, are constant, but the present invention is not limited to this. For example, unlike the illustration of FIG. 20, the inclination angles of the second inclined portions G12, G12' and the second portions 8152, 8152' increase as they approach the discharge port H8212. Therefore, the second inclined portions G12, G12' and the second portions 8152, 8152' each have a curved surface. It may include. The technical features disclosed in each embodiment of the present invention are not limited to the corresponding embodiment, and unless mutually incompatible, the technical features disclosed in each embodiment may be combined and applied to different embodiments. Therefore, although each embodiment will be described focusing on its respective technical features, they may be combined and applied as long as the technical features are not mutually incompatible. The present invention is not limited to the above-described embodiments and the accompanying drawings, and various modifications and variations are possible within the scope of those skilled in the art to which the present invention pertains. Therefore, the scope of the present invention should be determined not only by the claims of this specification but also by equivalents of the claims.

Claims

1. a housing having an outer wall that forms an internal space, the outer wall having a first portion that is coupled to a cartridge that stores a dosage form therein, and a second portion that is detachably attached to a dosage form dispenser while being coupled to the cartridge, and the housing accommodates the dosage form stored in the cartridge in the internal space by coupling the cartridge to the first portion; a rotor portion rotatably coupled to the housing in the internal space, which rotates in the internal space of the housing to dispense the dosage form contained in the internal space toward the dosage form dispenser; The first portion has an open structure, and when the cartridge is coupled to the first portion, the first portion accommodates the dosage form contained in the cartridge; The second part is an ejection unit that exposes an ejection port for ejecting the internal space toward the dosage form dispenser and a drive shaft portion of the rotor portion that connects to a rotor portion drive portion provided in the dosage form dispenser.

2. The dispensing unit of claim 1 , wherein the first portion is provided with a screw thread for releasably coupling with one end of the cartridge.

3. a discharge cap coupled to the second portion and closing the second portion; Further provided with the discharge cap has a rotor insertion opening into which a drive shaft of the rotor unit is inserted and the discharge opening, The discharge unit according to claim 1 , wherein the discharge port and the drive shaft of the rotor portion are exposed through the discharge cap.

4. The rotor portion has a dosage form guide port that is partially opened and receives the dosage form to be discharged to the discharge port. The discharge unit according to claim 1, wherein the dosage form guide port moves the dosage form seated therein to the discharge port by rotation of the rotor portion.

5. The discharge unit according to claim 4, wherein the dosage form induction port has a width and length such that a plurality of dosage forms can be arranged in a line within the dosage form induction port.

6. The dispensing unit according to claim 1 , wherein the housing further includes a housing guide portion that guides the insertion direction of the dispensing unit when the dispensing unit is attached to the dosage form dispenser.

7. The discharge unit according to claim 6, wherein the accommodation guide portion has a shape corresponding to the shape of a cartridge accommodation opening in the dosage form dispenser into which the discharge unit is inserted.

8. When the cartridge is installed in the dosage form dispenser, the cartridge is installed in a state where it is coupled to the first part of the housing, When the cartridge is attached to the dosage form dispenser, the drive shaft of the rotor part exposed to the second portion is connected to a rotor part drive part provided in the dosage form dispenser to rotate the rotor part, and the discharge port exposed to the second portion is connected to a discharge path of the dosage form provided in the dosage form dispenser, The dispensing unit according to claim 1, wherein the rotation of the rotor portion causes the dosage form in the cartridge to be dropped into the dosage form dispenser through the discharge port.

9. a cartridge containing the dosage form; The discharge unit according to claim 1 , which is coupled to the cartridge; Including, The cartridge is a dosage form cartridge assembly that is detachably attached to the dosage form dispenser while being coupled with the dispensing unit.

10. 10. The dosage form cartridge assembly according to claim 9, wherein one end of the cartridge has an open portion for being detachably coupled to the discharge unit, and the other end of the cartridge is closed.

11. 11. The dosage form cartridge assembly of claim 10, wherein the open portion of the cartridge is threaded to be releasably coupled to the first portion.

12. a storage unit having a plurality of cartridge storage openings into which dosage form cartridge assemblies each including the ejection unit according to claim 1 and the cartridge are inserted; a rotor driving unit connected to a rotor provided in the discharge unit of the dosage form cartridge assembly and driving the rotor; a control unit for controlling the rotor drive unit; 12. A dosage form dispenser comprising:

13. The dosage form dispenser according to claim 12, wherein when the dosage form cartridge assembly is inserted into one of the plurality of cartridge receiving openings, the second portion of the dispensing unit faces a bottom surface of the cartridge receiving opening.

14. 13. The dosage form dispenser of claim 12, wherein when the dosage form cartridge assembly is inserted into one of a plurality of cartridge storage ports of the dosage form dispenser, the rotor portion exposed to the second portion is connected to a motor shaft of the rotor portion driving unit, and the discharge port exposed to the second portion is connected to a discharge path of the dosage form provided in the storage unit.

15. The dosage form dispenser according to claim 12, wherein the storage unit further comprises an attachment sensor that senses whether the dosage form cartridge assembly attached to each cartridge receiving opening is attached.

16. The dosage form dispenser according to claim 12, wherein the cartridge receiving opening is formed in a groove shape.

17. The dosage form dispenser according to claim 12, wherein the housing further comprises a housing guide portion that guides the insertion direction of the dispensing unit when the dispensing unit is attached to the dosage form dispenser.

18. Each of the plurality of cartridge storage openings further includes a storage guide opening having a shape corresponding to the storage guide portion, The dosage form dispenser according to claim 17, wherein the storage guide portion is coupled to the storage guide opening when the dispensing unit is inserted into each of the cartridge storage openings.

19. The dosage form dispenser according to claim 12, wherein the storage unit further comprises a dispensed number sensor located below the dispense outlet and configured to sense the number of dosage forms dispensed from each of the plurality of dosage form cartridge assemblies.

20. The dosage form dispenser according to claim 12, wherein the storage unit further comprises an installation status indicator for indicating the installation status of each of the cartridge assemblies.

21. The storage unit further includes a sealing portion that seals a lower end of the storage unit so that the dosage forms discharged from each of the plurality of dosage form cartridge assemblies are discharged to the outside of the storage unit, The dosage form dispenser of claim 12, wherein the sealing portion opens the lower end of the storage unit while the dosage form is being ejected from each of the plurality of dosage form cartridge assemblies, and seals the lower end of the storage unit when the ejection operation from each of the plurality of dosage form cartridge assemblies is completed.

Images